Podcasts about Safety

In this episode, Ben Toombs, MBA, BSN, RN, Director of Emergency Programs at UW Health, and Nicholas Bell, Manager of Safety and Emergency Management at UW Health, share how systems can rethink mass casualty incident readiness beyond binders and annual drills. They discuss operational realities, governance and communication challenges, staff well-being, and how UW Health rebuilt its MCI approach through continuous learning and real-world testing.

The Buckeyes went to the transfer portal to replenish their safety losses from last season, but could true freshman safety Blaine Bradford make an impact as well?In this episode of the Buckeye Weekly Podcast, hosts Tony Gerdeman and Tom Orr discuss their expectations for Blaine Bradford as a freshman and why it wouldn't be a surprise to see him in the two-deep this season. 

As world leaders and tech bosses gather for India's AI Impact Summit, Danny Fortson and Mark Sellman ask if these global summits are shaping AI or struggling to keep up with it? They also hear from Carina Prunkl, lead author of the new International AI Safety Report, about risks, jobs, autonomy and whether safeguards are keeping pace with technology. Plus, OpenAI snaps up viral agent OpenClaw. Image: Getty Hosted on Acast. See acast.com/privacy for more information.

Send a text

Last episode we broke down the Offense position by position.  This episode we look at the defensive side of the ball.Jeff Chadiha (NFL Network/NFL.com/@JeffriChadiha), Sam McDowell (Kansas City Star/KCStar.com/@SamMcDowell11) and Soren Petro (Sports Radio 810 - WHB/810whb.com/@SorenPetro) break down each position group using a scale of 1 (best case) to 10 (worst case), to determine where the Chiefs Defense needs attention this offseason. - Really thin at Defensive Tackle!- After Karlaftis, there's not much at DE.- The linebackers should still be solid.- Corner looks good with McDuffie, without?- Safety is a problem!⁃ Conclusions.

Episode Summary: Robots Are Building Solar Farms Robots Are Building Solar Farms: How Cosmic Robotics Is Transforming Utility-Scale Construction In this episode of the Solar Maverick Podcast, host Benoy Thanjan sits down with James Emerick, Co-Founder and CEO of Cosmic Robotics, to explore how autonomous robotics are changing the way utility-scale solar is built. Cosmic Robotics is developing an autonomous vehicle with an industrial robotic arm that installs PV modules on to racking, reducing labor intensity while improving safety and predictability on job sites. James shares why module installation is one of the most labor-intensive and OSHA recordable injury-prone tasks in solar construction and how robotics can help crews work faster and safer. They also discuss the company's approach to deploying robots in the field, using real-world data to improve performance, and expanding into adjacent tasks like QA/QC and other construction applications over time. The conversation also touches on the broader drivers accelerating automation, including labor constraints, tighter project economics, and the surge in behind-the-meter power needs from data centers and AI infrastructure.   Key Takeaways Robotics can reduce crew size while maintaining or improving daily module install throughput • Safety is a primary driver, not just cost, since module install has high injury exposure • Well-scoped tasks like module placement are a practical path to field-ready autonomy • The long-term opportunity is a broader robotics platform for solar and adjacent infrastructure   Biographies Benoy Thanjan Benoy Thanjan is the Founder and CEO of Reneu Energy, solar developer and consulting firm, and a strategic advisor to multiple cleantech startups. Over his career, Benoy has developed over 100 MWs of solar projects across the U.S., helped launch the first residential solar tax equity funds at Tesla, and brokered $45 million in Renewable Energy Credits (“REC”) transactions. Prior to founding Reneu Energy, Benoy was the Environmental Commodities Trader in Tesla's Project Finance Group, where he managed one of the largest environmental commodities portfolios. He originated REC trades and co-developed a monetization and hedging strategy with senior leadership to enter the East Coast market. As Vice President at Vanguard Energy Partners, Benoy crafted project finance solutions for commercial-scale solar portfolios. His role at Ridgewood Renewable Power, a private equity fund with 125 MWs of U.S. renewable assets, involved evaluating investment opportunities and maximizing returns. He also played a key role in the sale of the firm's renewable portfolio. Earlier in his career, Benoy worked in Energy Structured Finance at Deloitte & Touche and Financial Advisory Services at Ernst & Young, following an internship on the trading floor at D.E. Shaw & Co., a multi billion dollar hedge fund. Benoy holds an MBA in Finance from Rutgers University and a BS in Finance and Economics from NYU Stern, where he was an Alumni Scholar.   James Emerick James Emerick is the Co-Founder and CEO of Cosmic Robotics, a construction equipment company building autonomous equipment for utility-scale solar. Cosmic's first product is an autonomous vehicle with an industrial robotic arm that installs PV modules on racking to make solar construction faster, safer, and more predictable.   Stay Connected: Benoy Thanjan Email: info@reneuenergy.com  LinkedIn: Benoy Thanjan Website: https://www.reneuenergy.com Website: https://www.solarmaverickpodcast.com/       James Emerick     Website: https://www.cosmicrobotics.com/     Linkedin:  https://www.linkedin.com/in/jamesemerick/   Please provide 5 star reviews      If you enjoyed this episode, please rate, review and share the Solar Maverick Podcast so more people can learn how to accelerate the clean energy transition.    Reneu Energy Reneu Energy provides expert consulting across solar and storage project development, financing, energy strategy, and environmental commodities. Our team helps clients originate, structure, and execute opportunities in community solar, C&I, utility-scale, and renewable energy credit markets. Email us at info@reneuenergy.com to learn more.   Solar Maverick Happy Hour During Intersolar San Diego on Feb 18th https://luma.com/7v50llsn            

Welcome back to another edition of Skol Stories. Vikings Legend Robert Grifiith joins Mark Rosen and Pete Bercich to talk about finding purpose after your professional football career comes to a close. Robert showcases the learning process surrounding his new business, applying a football mindset in life's daily challenges, the importance of finding happiness in your life after football, trying to cut out the noise when focusing on your goals, and the importance of creating meaningful relationships throughout your life. All of this and more is in this edition of Skol Stories. Be sure to check out Robert's upcoming NFL licensed bag line at [https://xooxbag.com](https://xooxbag.com)See omnystudio.com/listener for privacy information.

In this episode, Rena Malik, MD is joined by Dr. Jordan Feigenbaum to explore the science and myths around peptides, muscle health, and supplementation. They break down the realities of popular peptides like BPC-157, discuss the importance of resistance training for preventing age-related muscle loss, and offer practical advice on supplements, dietary guidelines, and exercise. Listeners will come away with clear, evidence-based recommendations for optimizing health and fitness amid today's trends and marketing hype. Become a Member to Receive Exclusive Content: renamalik.supercast.com Schedule an appointment with me: https://www.renamalikmd.com/appointments ▶️Chapters: 00:00:00 Introduction 00:00:38 Peptides “Glow Up” & Hype 00:01:12 What Peptides Actually Are 00:02:27 Zombie Drugs: Abandoned Pharma 00:04:03 Why They're Easy to Access 00:06:41 Not Supplements, Not Regulated 00:10:18 Research Chemical Loophole 00:18:52 BPC-157 Claims vs Evidence 00:27:34 Growth Hormone Secretagogues 00:34:47 Tesamorelin & Legit Medical Use 00:41:26 Peptides for Fat Loss 00:53:12 Retatrutide & Next-Gen GLP-1s 01:02:39 Safety, Dosing & Unknown Risks 01:15:22 Final Take: Are Peptides Worth It? Check out the Erectile Mastery Course: https://learn.renamalikmd.com/erectilemastery Stay connected with Dr. Jordan Feigenbaum on social media for daily insights and updates. Don't miss out—follow him now and check out these links! INSTAGRAM - https://www.instagram.com/jordan_barbellmedicine/?hl=en BARBELL MEDICINE'S INSTAGRAM - https://www.instagram.com/barbell_medicine/ WEBSITE - http://www.barbellmedicine.com/ Let's Connect!: WEBSITE: http://www.renamalikmd.com YOUTUBE: https://www.youtube.com/@RenaMalikMD INSTAGRAM: http://www.instagram.com/RenaMalikMD TWITTER: http://twitter.com/RenaMalikMD FACEBOOK: https://www.facebook.com/RenaMalikMD/ LINKEDIN: https://www.linkedin.com/in/renadmalik PINTEREST: https://www.pinterest.com/renamalikmd/ TIKTOK: https://www.tiktok.com/RenaMalikMD ------------------------------------------------------ DISCLAIMER: This podcast is purely educational and does not constitute medical advice. The content of this podcast is my personal opinion, and not that of my employer(s). Use of this information is at your own risk. Rena Malik, M.D. will not assume any liability for any direct or indirect losses or damages that may result from the use of information contained in this podcast including but not limited to economic loss, injury, illness or death. Learn more about your ad choices. Visit megaphone.fm/adchoices

Cold exposure is one of the simplest tools to improve discipline, resilience, and immune function, but most people quit because they don't know how to do it properly. In this episode, Dr. Derrick Hines breaks down his exact step-by-step cold shower protocol, including how to use breathwork to make the cold tolerable, how to avoid common mistakes, and how to train your brain to lean into discomfort instead of avoiding it. This is not about shock value. It is about building discipline, reducing inflammation, improving stress tolerance, and strengthening your immune response in a safe and repeatable way.In This Episode- Why cold exposure goes far beyond fat loss or “toughness”- The discipline benefits of activating your anterior mid-cingulate cortex- How breathwork changes your physiological response to cold- A detailed 5-step cold shower protocol- Why you should never skip the base-of-the-neck exposure- Safety guidelines for Wim Hof style breathing- How to avoid lightheadedness and blackouts- Why commitment for five days changes everything- How cold exposure may improve inflammation and immune resilience- The mental trigger that means you must do it that dayTikTok:https://www.tiktok.com/@drderrickInstagram:https://www.instagram.com/derrickbhines/Youtube:https://www.youtube.com/@DrDerrick

Send us an email @ info@parentcoachesunleashed.com SummaryIn this episode of Parent Coaches Unleashed, Carrie Wiesenfeld and Jessica Anger engage in a heartfelt conversation with Paige, a mother of a transgender daughter named Chloe. They explore the journey of recognizing Chloe's gender identity from a young age, the importance of support systems, medical guidance, and the challenges faced in social transition, sports participation, and dating. Paige shares her experiences, insights, and resources for parents navigating similar paths, emphasizing the need for open communication, understanding, and community support.TakeawaysIt's essential to recognize and support a child's gender identity early on.Language around gender identity is evolving, and parents should be open to learning.Building a network of allies is crucial for a transgender child's acceptance.Medical guidance should come from competent professionals familiar with transgender issues.Social transition should be approached methodically and with preparation.Coming out can be a significant event for transgender children and their families.Medical interventions like puberty blockers should be discussed with a knowledgeable team.Participation in sports can present unique challenges for transgender youth.Safety concerns for transgender individuals, especially in dating, are paramount.Community support, such as camps for transgender youth, can be life-changing.Resources1. www.genderspectrum.org   Many downloadable resources General, Family, Educational, Faith, Medical and Mental Health, Allyship, Book list. You can also get speakers and speak to professionals 2. www.thetrevorproject.orgNon profit LGBTQ plus youth   They have a suicide hotline and so many resources3. Local PFLAG  and LGBTQ Centers  in your city   Just google it   Many have support groups, activities, advocacy opportunities, groups for parents and grandparents as well4. Psychologytoday.com to find a therapist using the therapist finder. You can enter your location, issues, insurance, preferences and other criteria and it will give you names, specialties, and contact information5. For specialists in medical care, go to WPATH Provider Directory, and https://lgbtqhealthcaredirectory.org6. https://harborcamps.orgBooks 1. My Princess Boy by Cheryl Kilodavis2. Raising my Rainbow by Lori Duron3. The Transgender Child (and Teen ) by Stephanie Brill and Rachel Pepper4. Raising The Transgender Child by Michele Angello  

Misha Glenny and guests discuss one of the wonders of the natural world. In 1875 in the western Pacific, the crew of HMS Challenger discovered the Mariana Trench which turned out to be deeper than Everest is high, by two kilometres. Trenches like Mariana form when one tectonic plate slips under another and heads down and there are around fifty of them globally. While at one time some thought it was too dark and deep for life there and others wildly imagined monsters, the truth has turned out to be much more surprising. With Heather Stewart, Director of Kelpie Geoscience and Associate Professor at the University of Western AustraliaJon Copley Professor of Ocean Exploration and Science Communication at the University of SouthamptonAnd Alan Jamieson Director of the Deep Sea Research Centre at the University of Western AustraliaProducer: Simon TillotsonReading list:Susan Casey, The Underworld: Journeys to the Depths of the Ocean (Doubleday, 2023) Jon Copley, Deep Sea: 10 Things You Should Know (Orion Books, 2023)Hali Felt, Soundings: The Story of the Remarkable Woman Who Mapped the Ocean Floor (Henry Holt & Co, 2012)M.E. Gerringer, ‘Pseudoliparis swirei: A newly-discovered hadal liparid (Scorpaeniformes: Liparidae) from the Mariana Trench' (Zootaxa 4358 (1), 161-177, 2017)A.J. Jamieson, The Hadal Zone: Life in the Deepest Oceans (Cambridge University Press, 2015)A.J. Jamieson et al., ‘A global assessment of fishes at lower abyssal and upper hadal depths (5000 to 8000 m)' (Deep-Sea Research Part 1. 178: 103642, 2021)A.J. Jamieson et al., ‘Fear and loathing of the deep ocean: Why don't people care about the deep sea?' (ICES Journal of Marine Science. 78: 797-809, 2020)A.J. Jamieson et al., ‘Microplastic and synthetic fibers ingested by deep-sea amphipods in six of the deepest marine environments on Earth' (Royal Society Open Science, 6, 180667, 2019)A.J. Jamieson et al., ‘Bioaccumulation of persistent organic pollutants in the deepest ocean fauna' (Nature Ecology and Evolution. 1, 0051, 2017)V.L. Vescovo et al., ‘Safety and conservation at the deepest place on Earth: A call for prohibiting the deliberate discarding of nondegradable umbilicals from deep-sea exploration vehicles' (Marine Policy. 128, 104463, 2021)J.N.J. Weston et al., ‘New species of Eurythenes from hadal depths of the Mariana Trench, Pacific Ocean (Crustacea: Amphipoda)' (Zootaxa. 4748(1): 163-181, 2020)In Our Time is a BBC Studios ProductionSpanning history, religion, culture, science and philosophy, In Our Time from BBC Radio 4 is essential listening for the intellectually curious. In each episode, host Misha Glenny and expert guests explore the characters, events and discoveries that have shaped our world.

A Note from James:In the first episode with Dr. Nicole McNichols, we talked about chemistry, myths, and why communication matters more than performance. This episode goes deeper—into biology, anatomy, dopamine, desire, and the mechanics of pleasure.There are a lot of myths around sex. Some are cultural. Some are Hollywood. Some come from bad science. And some just come from silence.This conversation gets specific. We talk about orgasm, desire, scheduling sex, the so-called “missionary problem,” novelty in long-term relationships, and why so much of what we assume about men and women sexually just isn't true.If Part 1 was about mindset, Part 2 is about understanding how sex actually works.Episode Description:What actually happens in the body during orgasm? Why does anticipation sometimes feel better than the act itself? And why are so many of our beliefs about sex simply wrong?In Part 2 of this three-part series, Dr. Nicole McNichols breaks down the biology of desire, the science of orgasm, and the myths that quietly sabotage long-term relationships.She explains why dopamine peaks during anticipation, why consistency—not intensity—is often key to orgasm, and why “missionary” might be underrated. They explore the anatomy of the clitoris (including research only fully mapped in 2006), the orgasm gap, responsive vs. spontaneous desire, and why scheduling intimacy can actually increase desire.This episode reframes sex not as performance, but as collaboration—an evolving, communicative process rooted in curiosity and growth.What You'll Learn:Why dopamine spikes during anticipation—and how to avoid the post-expectation letdownThe difference between spontaneous and responsive desire (for both men and women)Why consistency is physiologically critical during orgasmThe science behind the orgasm gap and what actually closes itWhy scheduling intimacy can increase frequency and desire—not kill spontaneityTimestamped Chapters:[00:02:00] No One Craves Bad Sex & The Myth of “Boring” Positions[00:03:18] Previously on Part 1: Porn Myths & Feeling Wanted[00:04:00] Chemistry, Pheromones & The Role of Safety[00:06:00] Sexual Growth Mindset & Compatibility[00:08:00] Fireworks vs. Communication[00:10:00] Anatomy, Diversity of Touch & The Clitoris Explained[00:12:00] Scripts, Feedback & How to Talk During Sex[00:17:00] Novelty, Micro-Novelty & Preventing Boredom[00:19:00] Wanting, Liking & Learning: The Pleasure Cycle[00:23:00] Expanding the Definition of Sex[00:25:00] The “Sex Recession” & Frequency Myths[00:27:00] Planning Intimacy & Scheduling Sex[00:31:00] Why Missionary Deserves a Rebrand[00:34:00] Internal Anatomy, the Clitoral Complex & Size Myths[00:39:00] What Is an Orgasm, Physiologically?[00:45:00] The Orgasm Gap & Why Fingering Matters[00:47:00] Consistency vs. “Faster & Harder”[00:49:00] Masturbation Myths & No Nut November[00:51:00] Refractory Period & Aging[00:55:00] Multiple Orgasms & What Research Shows[01:00:00] Love, Orientation & Novelty in Long-Term RelationshipsAdditional Resources:You Could Be Having Better SexNicole McNicholsHelen O'Connell – Research mapping full clitoral anatomy (MRI studies)Beverly Whipple – Orgasm research & physiological studiesA Moveable Feast – Referenced during discussionSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Christine, a 73-year-old living with Type 1 for 67 years, reflects on the evolution of diabetes tech and the resilience required to thrive through nearly seven decades of management. Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** Use code JUICEBOX to save 40% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

Barb and Spencer explore the vital topic of boundaries in depth, offering insights into how establishing and maintaining boundaries can significantly impact one's emotional well-being. Barb, a boundaries coach, shared personal experiences and wisdom gained from her own recovery journey, shedding light on how boundaries play a critical role in understanding oneself and improving relationships... The post Healthy Boundaries Create Internal Safety – 448 appeared first on The Recovery Show.

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3463: Darrow Kirkpatrick explores the hidden risks of managing wealth in a digital age, from rare system failures to physical disasters that could wipe out essential documents. He offers clear, actionable strategies to keep your finances resilient like diversifying accounts, securing digital backups, and protecting vital records at home and in the cloud. Read along with the original article(s) here: https://www.caniretireyet.com/protecting-your-assets-in-a-digital-world/ Quotes to ponder: "The simplest way to protect yourself against computer glitches may be to diversify your assets around at multiple institutions." "The most reliable way to protect your important documents these days is to convert as many of them as possible to electronic form and save them in the cloud." "If you've worked hard in life it only makes sense to take some reasonable measures to protect what you've achieved." Episode references: Sentry Safes: https://www.sentrysafe.com Dropbox: https://www.dropbox.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: Standardized safety protocols across providers Integration support, not medication alone Clear training pathways for clinicians Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: Veterans are likely the first federal pathway Public education remains essential Safety standards must be shared and transparent Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing Melissa Lavasani & Jay Kopelman provide a grounded look at how psychedelic policy develops inside federal systems. Their message is practical: veterans may be the first lane, but long-term success depends on coordination, safety standards, and sustained engagement. Closing This episode captures a real-time view of how federal policy could shape the next phase of the psychedelic resurgence, especially through veteran-facing legislation and VA infrastructure. Melissa Lavasani & Jay Kopelman argue that coordination, public education, and shared safety standards will shape whether access expands with credibility and care. Transcript Joe Moore: [00:00:00] Hello everybody. Welcome back to Psychedelics Today. Today we have two guests, um, got Melissa Sani from Psychedelic Medicine Coalition. We got Jake Pelman from Mission Within Foundation. We're gonna talk about I bga I became policy on a recent, uh, set of meetings in Washington, DC and, uh, all sorts of other things I'm sure. Joe Moore: But thank you both for joining me. Melissa Lavasani: Thanks for having us. Jay Kopelman: Yeah, it's a pleasure. Thanks. Joe Moore: Yeah. Um, Melissa, I wanna have you, uh, jump in. First. Can you tell us a little bit about, uh, your work and what you do at PMC? Melissa Lavasani: Yeah, so Psychedelic Medicine Coalition is, um, the only DC based Washington DC based advocacy organization dedicated to the advancing the issue of psychedelics, um, and making sure the federal government has the education they need, um, and understands the issue inside out so that they can generate good policy around, around psychedelic medicines. Melissa Lavasani: [00:01:00] Uh, we. Host Hill events. We host other convenings. Our big event every year is the Federal Summit on psychedelic medicine. Um, that's going to be May 14th this year. Um, where we talk about kinda the pressing issues that need to be talked about, uh, with government officials in the room, um, so that we can incrementally move this forward. Melissa Lavasani: Um, our presence here in Washington DC is, is really critical for this issue's success because, um, when we're talking about psychedelic medicines, um, from the federal government pers perspective, you know, they are, they are the ones that are going to initiate the policies that create a healthcare system that can properly facilitate these medicines and make sure, um, patient safety is a priority. Melissa Lavasani: And there's guardrails on this. And, um, you know, there, it's, it's really important that we have. A home base for this issue in Washington DC just [00:02:00] because, uh, this is very complicated as a lot of your viewers probably understand, and, you know, this can get lost in the mix of all the other issues that, um, lawmakers in DC are focused on right now. Melissa Lavasani: And we need to keep that consistent presence here so that this continues to be a priority for members of Congress. Joe Moore: Mm. I love this. And Jay, can you tell us a bit about yourself and mission within Foundation? Jay Kopelman: Yeah, sure. Joe, thanks. Uh, I, I am the CEO of Mission within Foundation. Prior to this, most of my adult life was spent in the military as a Marine. Jay Kopelman: And I came to this. Role after having, uh, a psychedelic assisted therapy experience myself at the mission within down in Mexico, which is where pretty much we all go. Um, we are here to help [00:03:00] provide, uh, access for veterans and first responders to be able to attend psychedelic assisted therapy retreats to treat issues like mild TBI, post-traumatic stress disorder, uh, depression, sometimes addiction at, at a very low level. Jay Kopelman: Um, and, and so we've, we've been doing this for a little more than a year now and have provided 250 plus scholarships to veterans and first responders to be able to access. These retreats and these, these lifesaving medicines. Um, we're also partnered, uh, you may or may not know with Melissa at Psychedelic Medicine Coalition to help advance education and policy, specifically the innovative, uh, therapy Centers of Excellence Act [00:04:00] that Melissa has worked for a number of years on now to bring to both Houses of Congress. Joe Moore: Thank you for that. Um, so let's chat a little bit about what this event was that just, uh, went down, uh, what, what was it two weeks ago at this point? Melissa Lavasani: Yeah. Yeah. It's called For Veteran Society and it's all, um, there's a lot of dialogue on Capitol Hill about veterans healthcare and psychedelics, but where I've been frustrated is that, you know, it was just a lot of. Melissa Lavasani: Talk about what the problems are and not a lot of talk about like how we actually propel things forward. Um, so it, at that event, I thought it was really important and we had three members of Congress there, um, Morgan Latrell, who has been a champion from day one and his time in Congress, um, having gone through the experience himself, um, [00:05:00] at Mission within, um, and then the two chairs of the psychedelic caucus, uh, Lou Correa and Jack Bergman. Melissa Lavasani: And we really got down to the nitty gritty of like w like why this has taken so long and you know, what is actually happening right now? What are the possibilities and what the roadblocks are. And it was, I thought it was a great conversation. Um, we had an interesting kind of dynamic with Latres is like a very passionate about this issue in particular. Melissa Lavasani: Um, I think it was, I think it was really. A great event. And, you know, two days later, Jack Bergman introduced his new bill for the va. Um, so it was kind of like the precursor to that bill getting introduced. And we're just excited for more and more conversations about how the government can gently guide this issue to success. Joe Moore: Hmm. Yeah. [00:06:00] That's fantastic. Um, yeah, I was a little bummed I couldn't make it, but next time, I hope. But I've heard a lot of good things and, um, it's, it sounded like there was some really important messages in, in terms of like feedback from legislators. Yeah. Yeah. Could you speak to that? Melissa Lavasani: Yeah, I mean, I think when, uh, representative Latrell was speaking, he really impressed on us a couple things. Melissa Lavasani: Um, first is that, you know, they really kind of need the advocates to. Coordinate, collaborate and come up with like a, a strategic plan, you know, without public education. Um, talking to members of Congress about this issue is, is really difficult. You know, like PMC is just one organization. We're very little mission within, very little, um, you know, we're all like, kind of new in navigating, um, this not so new issue, but new to Washington DC [00:07:00] issue. Melissa Lavasani: Um, without that public education as a baseline, uh, it's, it's, you have to spend a lot of time educating members of Congress. You know, that's like one of our things is, you know, we have to, we don't wanna tell Congress what direction to go to. We wanna provide them the information so they understand it very intimately and know how to navigate through things. Melissa Lavasani: Um, and secondly. Um, he got pretty frank with us and said, you know, we've got one cha one chance at this issue. And it's like, that's, that's kind of been like my talking point since I started. PMC is like, you have a very limited window, um, when these kind of issues pop up and they're new and they're fresh and you have a lot of the veteran community coming out and talking about it. Melissa Lavasani: And there's a lot of energy there. But now is the time to really move forward, um, with some real legislation that can be impactful. Um, but, you know, we've gotta [00:08:00] be careful. We, we forget, I think sometimes those of us who are in the ecosystem forget that our level of knowledge about these medicines and a lot of us have firsthand experience, um, with these drugs and, and our own healing journeys is, um, we forget that there is a public out there that doesn't have the level of knowledge that we all have. Melissa Lavasani: And, um. We gotta make sure that we're sticking to the right elements of, of, of what needs to happen. We need to be sure that our talking points are on track and we're not getting sideways about anything and going down roads that we don't need to talk about. It's why, um, you know, PMC is very focused on, um, moving forward veteran legislation right now. Melissa Lavasani: Not because we're a veteran organization, but because we're, we see this long-term policy track here. Um, we know where we want to get [00:09:00] to, um. Um, and watching other healthcare issues kind of come up and then go through the VA healthcare system, I think it's a really unique opportunity, um, to utilize the VA as this closed system, the biggest healthcare system in the country to evaluate, uh, how psychedelics operate within systems like that. Melissa Lavasani: And, you know, before they get into, um, other healthcare systems. What do we need to fix? What do we need to pay attention to? What's something that we're paying too much attention to that doesn't necessarily need that much attention? So it's, um, it's a real opportunity to look at psychedelic medicines within a healthcare system and obviously continue to gather the data. Melissa Lavasani: Um, Bergman's Bill emerging, uh, expanding veteran access to emerging treatments. Um, not only mandates the research, it gives the VA authority for this, uh, for running trials and, and creating programs around psychedelic medicines. But also, [00:10:00] one of the great things about it, I think, is it provides an on-ramp for veterans that don't necessarily qualify for clinical trials. Melissa Lavasani: You know, I think that's one of the biggest criticisms of clinical trials is like you're cre you're creating a vacuum for people and people don't live in a vacuum. So we don't necessarily know what psychedelics are gonna look like in real life. Um, but with this expanding veteran access bill that Bergman introduced, it provides the VA an opportunity to provide this access under. Melissa Lavasani: Um, in a, in a safe container with medical supervision while collecting data, um, while ensuring that the veteran that is going through this process has the support systems that it needs. So, um, you know, I think that there's a really unique opportunity here, and like Latrell said, like, we've got one shot at this. Melissa Lavasani: We have people's attention in Congress. Um, now's the time to start acting, and let's be really considerate and thoughtful about what we're doing with it. Joe Moore: Thanks for that, Melissa and Jay, how, [00:11:00] anything to add there on kind of your takeaways from the this, uh, last visit in dc? Jay Kopelman: Yeah, I, I think that Melissa highlighted it really well and there, there were a couple other things that I, I think, you know, you could kind of tie it all together with some other issues that we face in this country, uh, and that. Jay Kopelman: Uh, representative Correa brought up as well, but one of the things I wanted to go back and say is that veterans have kind of led this movement already, right? So, so it's a, it's a good jumping off point, right? That it's something people from both sides of the aisle, from any community in America can get behind. Jay Kopelman: You know, if you think about it, uh, in World War ii, you know, we had a million people serving our population was like, not even 200 million, but now [00:12:00] we have a population of 330 million, and at any given time there might be a million people in uniform, including the Reserve and the National Guard. So it's, it, it's an easy thing to get behind this small part of the population that is willing to sign that contract. Jay Kopelman: Where you are saying, yeah, I'm going to defend my country, possibly at the risk of my l my own life. So that's the first thing. The other thing is that the VA being a closed health system, and they don't have shareholders to answer to, they can take some risks, they can be innovative and be forward thinking in the ways that some other healthcare systems can't. Jay Kopelman: And so they have a perfect opportunity to show that they truly care for their veterans, which don't, I'm not saying they don't, but this would be an [00:13:00] opportunity to show that carrot at a whole different level. Uh, it would allow them to innovate and be a leader in something as, uh, as our friend Jim Hancock will say, you know. Jay Kopelman: When he went to the Naval Academy, they had the world's best shipbuilding program. Why doesn't the VA have the world's best care program for things like TBI and PTSD, which affects, you know, 40 something percent of all veterans, right? So, so there's, there's an opportunity here for the VA to lead from the front. Jay Kopelman: Um, the, these medicines provide, you know, reasonably lasting care where it's kind of a one and done. Whereas with the current systems, the, you know, and, and [00:14:00] again, not to denigrate the VA in any way, they're doing the best job they can with the tools in their toolbox, right? But maybe it's time for a trip to Home Depot. Jay Kopelman: Let's get some new tools. And have some new ways of fixing what's broken, which is really the way of doing things. It's not, veterans aren't broken, we are who we are. Um, but it's a, it's a way to fix what isn't working. So I, I think that, you know, given there's tremendous veteran homelessness still, you know, addiction issues, all these things that do translate to the population at large are things that can be worked on in this one system, the va that can then be shown to have efficacy, have good data, have [00:15:00] good outcomes, and, and take it to the population at large. Joe Moore: Mm-hmm. Brilliant. Thanks for that. And so there was another thing I wanted to pivot to, which is some of the recent press. So we've, um, seen a little bit of press around some, um, in one instance, some bad behavior in Mexico that a FI put out Americans thrive again, put out. And then another case there was a, a recent fatality. Joe Moore: And I think, um, both are tragic. Like we shouldn't be having to deal with this at this point. Um, but there's a lot of things that got us here. Um, it's not necessarily the operator's fault entirely, um, or even at all, honestly, like some medical interventions just carry a lot of risk. Like think, think about like, uh, how risky bypass surgery was in the nineties, right? Joe Moore: Like people were dying a lot from medical interventions and um, you know, this is a major intervention, uh, ibogaine [00:16:00] and also a lot of promise. To help people quite a bit. Um, but as of right now, there's, there's risk. And part of that risk, in my opinion, comes from the inability of organizations to necessarily collaborate. Joe Moore: Like there's no kind of convening body, sitting in the middle, allowing, um, for, and facilitating really good data sharing and learnings. Um, and I don't, I don't necessarily see an organization stepping up and being the, um, the convener for that kind of work. I've heard rumors that something's gonna happen there, and I'm, I'm hopeful I'll always wanna share my opinion on that. Joe Moore: But yeah. I don't know. Jay, from your perspective, is there anything you want to kind of speak to about, uh, these two recent incidents that Americans for Iboga kind of publicized recently? Jay Kopelman: Yeah, so I, I'll echo your sentiment, of course, that these are tragic incidents. Um, and I, [00:17:00] I think that at least in the case of the death at Ambio, AMBIO has done a very good job of talking about it, right? Jay Kopelman: They've been very honest with the information that they have. And like you said, there are risks inherent to these medicines, and it's like anything else in medicine, there are going to be risks. You know, when I went through, uh, when I, when I went through chemo, you know, there were, there are risks. You know, you don't feel well, you get sick. Jay Kopelman: Um, and, and it. There are processes in place to counter that when it happens. And there are processes and, and procedures and safety protocols in place when caring for somebody going through an ibogaine [00:18:00] journey. Uh, when I did it, we had EKG echocardiogram. You're on a heart monitor the entire time they push magnesium via iv. Jay Kopelman: You have to provide a urinalysis sample to make sure that there is nothing in your system that is going to potentially harm you. During the ibogaine, they have, uh, a cardiologist who is monitoring the heart monitors throughout the ibogaine experience. So the, the safety protocols are there. I think it's, I think it's just a matter of. Jay Kopelman: Standardizing them across all, all providers, right? Like, that would be a good thing if people would talk to one another. Um, as, as in any system, right? You've gotta have [00:19:00] some collaboration. You've gotta have standardization, you know, so, you know, they're not called standard operating procedures for nothing. Jay Kopelman: That means that in a, you know, in a given environment, everybody does things the same way. It's true in Navy and Marine Corps, air Force, army Aviation, they have standard operating procedures for every single aircraft. So if you fly, let's say the F 35 now, right? Because it's flown by the Navy, the Marine Corps, and the Air Force. Jay Kopelman: The, the emergency procedures in that airplane are standardized across all three services, so you should have the same, or, you know, with within a couple of different words, the same procedures and processes [00:20:00] across all the providers, right? Like maybe in one document you're gonna change, happy to glad and small dog to puppy, but it's still pretty much the, the same thing. Jay Kopelman: And as a service that provides scholarships to people to go access these medicines and go to these retreats, you know, my criteria is that the, this provider has to be safe. Number one, safety's paramount. It's always gotta be very safe. It should, it has to be effective. And you know, once you have those two things in place, then I have a comfort level saying, okay, yeah, we'll work with this provider. Jay Kopelman: But until those standardized processes are in place, you'll probably see these one-off things. I mean, some providers have been doing this longer than others and have [00:21:00] really figured out, you know, they've, they've cracked the code and, you know, sharing that across the spectrum would be good. Um, but just when these things happen, having a clearing house, right, where everybody can come together and talk about it, you know, like once the facts are known because. Jay Kopelman: To my knowledge, we still don't know all the facts. Like as, you know, as horrible as this is, you still have to talk about like an, has an autopsy been performed? What was found in the patient's system? You know, there, there are things there that we don't know. So we need to, we need to know that before we can start saying, okay, well this is how we can fix that, because we just don't know. Jay Kopelman: And, you know, to their credit, you know, Amio has always been safe to, to the, to the best of my knowledge. You know, I, [00:22:00] I haven't been to Ambio myself, but people that I have worked with have been there. They have observed, they have seen the process. They believe it's safe, and I trust their opinion because they've seen it elsewhere as well. Jay Kopelman: So yeah, having, having that one place where we can all come together when this happens, it, it's almost like it should be mandatory. In the military when there's a training accident, we, you know, we would have to have what's called a safety standout. And you don't do that again for a little while until you figure out, okay, how are we going to mitigate that happening again? Jay Kopelman: Believe me, you can go overboard and we don't want to do that. Like, we don't wanna just stop all care, but maybe stop detox for a week and then come back to it. [00:23:00] Joe Moore: Yeah. A dream would be, let's get like the, I don't know, 10, 20 most popular, uh, or well-known operators together somewhere and just do like a three day debrief. Joe Moore: Hey, everybody, like, here's what we see. Let's work on this together. You know how normal medicine works. And this is, it's hard because this is not necessarily, um, something people feel safe about in America talking about 'cause it's illicit here. Um, I don't understand necessarily how the operations, uh, relate to each other in Mexico, but I think that's something to like the public should dig into. Joe Moore: Like, what, what is this? And I, I'll start digging into that. Um, I, I asked a question recently of somebody like, is there some sort of like back channel signal everybody's using and there's no clear Yes. You know? Um, I think it would be good. That's just a [00:24:00] start, you know, that's like, okay, we can actually kind of say hi and watch out for this to each other. Jay Kopelman: It's not like we don't all know one another, right? Joe Moore: Yes. Jay Kopelman: Like at least three operators we're represented. At the Aspen Ibogaine meeting. So like that could be, and I think there was a panel kind of loosely related to this during Aspen Ibogaine meeting, but Joe Moore: mm-hmm. Jay Kopelman: It, you know, have a breakout where the operators can go sit down and kind of compare notes. Joe Moore: Right. Yeah. Melissa, do you have any, uh, comments on this thread here? And I, I put you on mute if you didn't see that. Um, Melissa Lavasani: all right, I'm off mute. Um, yeah, I think that Jay's hits the nail on the head with the collaboration thing. Um, I think that it's just a [00:25:00] problem across the entire ecosystem, and I think that's just a product of us being relatively new and upcoming field. Melissa Lavasani: Um, uh, it's a product of, you know. Our fundraising community is really small, so organizations feel like they are competing for the same dollars, even though their, their goals are all the same, they have different functions. Um, I think with time, I mean, let's be honest, like if we don't start collaborating and, and the federal government's moving forward, the federal government's gonna coordinate for us. Melissa Lavasani: And not, that might not necessarily be a bad thing, but, you know, we understand this issue to a whole other level that the federal government doesn't, and they're not required to understand it deeply. They just need to know how to really move forward with it the proper way. Um, but I think that it. It's really essential [00:26:00] that we all have this come together moment here so we can avoid things. Melissa Lavasani: Uh, I mean, no one's gonna die from bad advocacy. So like I've, I have a bit of an easier job. Um, but it can a, a absolutely stall efforts, um, to move things forward in Washington DC when, um, one group is saying one thing, another group is saying another thing, like, we're not quite at a point yet where we can have multiple lines of conversation and multiple things moving forward. Melissa Lavasani: Um, you know, for PMC, it's like, just let's get the first thing across the finish line. And we think that is, um, veteran healthcare. And, um, I know there's plenty of other groups out there that, that want the same thing. So, you know, I always, the reason why I put on the Federal Summit last year was I kind of hit my breaking point with a lack of collaboration and I wanted to just bring everyone in the same room and say like, all right, here are the things that we need to talk about. Melissa Lavasani: And I think the goal for this year is, um. To bring people in the same room and say, we talked about [00:27:00] we scratched the surface last year and this is where we need to really put our efforts into. And this is where the opportunities are. Um, I think that is going to, that's going to show the federal government if we can organize ourselves, that they need to take this issue really seriously. Melissa Lavasani: Um, I don't think we've done a great job at that thus far, but I think there's still plenty of time for us to get it together. Um, and I'm hoping with these two, uh, VA bills that are in the house right now and Senate is, is putting together their version of these two bills, um, so that they can move in tandem with each other. Melissa Lavasani: I think that, you know, there's an opportunity here for. Us to show the federal government as an ecosystem, Hey, we, we are so much further ahead and you know, this is what we've organized and here's how we can help you, um, that would make them buy into this issue a bit more and potentially move things forward faster. Melissa Lavasani: Uh, at this point in time, it's, I think that, [00:28:00] you know, psychedelics aren't necessarily the taboo thing that they, they used to be, but there's certainly places that need attention. Um, there's certainly conversations that need to be had, and like I said, like PMC is just one organization that can do this. Um, we can certainly organize and drive forward collaboration, but I, like we alone, cannot cover all this ground and we need the subject matter experts to collaborate with us so we can, you know, once we get in the door, we wanna bring the experts in to talk to these officials about it. Melissa Lavasani: So I. I, I really want listeners to really think about us as a convener of sorts when it comes to federal policy. Um, and you know, I think when, like for example, in the early eighties, a lot of people have made comparisons to the issue of psychedelics to the issue of AIDS research and how you have in a subject matter that's like extremely taboo and a patient population that the government [00:29:00] quite honestly didn't really care about in the early eighties. Melissa Lavasani: But what they did as an ecosystem is really organized themselves, get very clear on what they wanted the federal government to do. And within a matter of a couple years, uh, AIDS research funding was a thing that was happening. And what that, what that did was that ripple effect turned that into basically finding new therapies for something that we thought was a death, death sentence before. Melissa Lavasani: So I think. We just need to look at things in the past that have been really successful, um, and, and try to take the lessons from all of these issues and, and move forward with psychedelics. Joe Moore: Love that. And yes, we always need to be figuring out efficient approaches and where it has been successful in the past is often, um, an opportunity to mimic and, and potentially improve on that. Melissa Lavasani: Yeah. Jay Kopelman: One, one thing I think it's important to add to this part of the conversation is that, [00:30:00] you know, Melissa pointed out there are a number of organizations that are essentially doing the same thing. Jay Kopelman: Um, you know, I like to think we do things a little bit differently at Mission within Foundation in that we don't target any one specific type of service member. We, we work with all veterans. We work with first responders, but. What that leads to is that there are, as far as I've seen, nothing but good intentioned people in this space. Jay Kopelman: You know, people who really care about their patient population, they care about healing, they are trying to do a good job, and more importantly, they're trying to do good. Right? It, it, I think they all see the benefit down the road that this has, [00:31:00] pardon me, not just for veterans, but for society as a whole. Jay Kopelman: And, and ultimately that's where I would like to see this go. You know, I, I would love to see the VA take this. Take up this mantle and, and run with it and provide great data, great outcomes. You know, we are doing some data collection ourselves at Mission within foundation, albeit anecdotal based on surveys given before and after retreats. Jay Kopelman: But we're also working with, uh, Greg Fonzo down at UT Austin on a brain study he's doing that will have 40 patients in it when it's all said and done. And I think we have two more guys to put through that. Uh, and then we'll hit the 40. So there, there's a lot of good here that's being done by some really, really good people who've been doing this for a long time [00:32:00] and want to want nothing more than to, to see this. Jay Kopelman: Come to, come full circle so that we can take care of many, many, many people. Um, you know, like I say, I, I wanna work myself out of a job here. I, I just, I would love to see this happen and then I, you know, I don't have to send guys to Mexico to do this. They can go to their local VA and get the care that they need. Jay Kopelman: Um, but one thing that I don't think we've touched on yet, or regarding that is that the VA isn't designed for that. So it's gonna be a pretty big lift to get the right types of providers into the va with the knowledge, right, with the institutional knowledge of how this should be done, what is safe, what is effective, um, and then it, it's not just providing these medicines to [00:33:00] people and sending them home. Jay Kopelman: You don't just do that, you've gotta have the right therapists on the backend who can provide the integration coaching to the folks who are receiving these medicines. And I'm not just talking, I bga, even with MDMA and psilocybin, you should have a proper period of integration. It helps you to understand how this is going to affect you, what it, what the experience really meant, you know, because it's very difficult sometimes to just interpret it on your own. Jay Kopelman: And so what the experience was and what it meant to you. And, and so it will take some time to spin all that up. But once it's, once it's in place, you know, the sky's the limit. I think. Joe Moore: Kinda curious Jay, about what's, what's going on with Ibogaine at the federal level. Is there anything at VA right now? [00:34:00] Jay Kopelman: At the va? No, not with ibogaine. And, you know, uh, we, we send people specifically for IBOGAINE and five MEO, right? And, and so that, that doesn't preclude my interest in seeing this legislation passed, right? Jay Kopelman: Because it, it will start with something like MDMA or psilocybin, but ultimately it could grow to iboga, right? It the think about the cost savings at, at the va, even with psilocybin, right? Where you could potentially treat somebody with a very inexpensive dose of psilocybin or, or iboga one time, and then you, you don't have to treat them again. Jay Kopelman: Now, if I were, uh, you know, a VA therapist who's not trained in psychedelic trauma therapy. I might be worried [00:35:00] about job security, but it's like with anything, right? Like ultimately it will open pathways for new people to get that training or the existing people to get that training and, and stay on and do that work. Jay Kopelman: Um, which only adds another arrow to their quiver as far as I'm concerned, because this is coming and we're gonna need the people. It's just like ai, right? Like ai, yeah. Some people are gonna lose some jobs initially, and that's unfortunate. But productivity ultimately across all industries will increase and new jobs will be created as a result of that. Jay Kopelman: I mean, I was watching Squawk Box one morning. They were talking about the AI revolution and how there's gonna be a need for 500,000 electricians to. Build these systems that are going to work with the AI [00:36:00] supercomputers and, and so, Joe Moore: mm-hmm. Jay Kopelman: Where, where an opportunity may be lost. I think several more can be gained going forward. Melissa Lavasani: And just to add on what Jay just said there, there's nothing specific going on with Ibogaine at, at the va, but I think this administration is, is taking a real look at addiction in particular. Uh, they just launched, uh, a new initiative, uh, that's really centered on addiction treatments called the Great American Recovery. Melissa Lavasani: And, um, they're dedicating a hundred million dollars towards treating addiction as like a chronic treatable disease and not necessarily a law enforcement issue. So, um, in that initiative there will be federal grant programs for prevention and treatment and recovery. And, um, while this isn't just for psychedelic medicines, uh, I think it's a really great opportunity for the discussion of psychedelics to get elevated to the White House. Melissa Lavasani: Um, [00:37:00] there's also, previous to this announcement last week from the White House, there's been a hundred million dollars that was dedicated at, um, at ARPA h, which is. The advanced research projects, uh, agency for healthcare, um, and that is kind of an agency that's really focused on forward looking, um, treatments and technologies, uh, for, um, a, a whole slew of. Melissa Lavasani: Of issues, but this a hundred million dollars is dedicated to mental health and addiction. So there's a lot of opportunity there as well. So we, while I think, you know, some people are talking about, oh, we need a executive order on Iboga, it's like, well, you know, the, the president is thinking, um, about, you know, what issues can land with his, uh, voting block. Melissa Lavasani: And I think it's, I don't think we necessarily need a specific executive order on Iboga to call this a success. It's like, let's look at what, [00:38:00] um, what's just been announced from the White House. They're, they're all in on. Thinking creatively and finding, uh, new solutions for this. And this is kind of, this aligns with, um, HHS secretaries, uh, Robert F. Melissa Lavasani: Kennedy Junior's goals when he took on this, this role of Health Secretary. Um, addiction has been a discussion that, you know, he has personal, um, a personal tie to from his own experience. And, um, I think when this administration started, there was so much like fervor around the, the dialogue of like, everyone's talking about psychedelics. Melissa Lavasani: It was Secretary Kennedy, it was, uh, secretary Collins at the va. It was FDA Commissioner Marty Macari. And I think that there's like a lot of undue frustration within folks 'cause um, you don't necessarily snap your fingers and change happens in Washington dc This is not the city for that. And it's intentionally designed to move slow so that we can avoid really big mistakes. Melissa Lavasani: Um. [00:39:00] I think we're a year into this administration and these two announcements are, are pretty huge considering, um, you know, the, we, there are known people within domestic policy council that don't, aren't necessarily supportive of psychedelic medicine. So there's a really amazing progress here, and frustrating as it might be to, um, just be waiting for this administration to make some major move. Melissa Lavasani: I think they are making major moves like for Washington, DC These, these are major moves and we just gotta figure out how we can, um, take these initiatives and apply them to the issue of psychedelic medicines. Joe Moore: Thanks, Melissa. Um, yeah, it is, it is interesting like the amount of fervor there was at the beginning. You know, we had, uh. Kind of one of my old lawyers, Matt Zorn, jumped in with the administration. Right. And, um, you know, it was, uh, really cool to [00:40:00] see and hopeful how much energy was going on. It's been a little quiet, kind of feels like a black box a little bit, but I, you know, there was, Melissa Lavasani: that's on me. Melissa Lavasani: Maybe I, we need to be more out in public about like, what's actually happening, because I feel like, like day in and day out, it's just been, you gotta just mm-hmm. Like have that constant beat with the government. Mm-hmm. And, um, it's, it's, it's not the photo ops on the hill, it's the conversations that you have. Melissa Lavasani: It's the dinner parties you go to, it's the fundraisers you attend, you know? Mm-hmm. That's why I, I kind of have to like toot my own horn with PCs. Like, we need to be present here at, at not only on the Hill, not only at the White House, but kind of in the ecosystem of Washington DC itself. There's, it's, there are like power players here. Melissa Lavasani: There are people that are connected that can get things done, like. I mean, the other last week we had a big snow storm. I walked over to my friend's house, um, to have like a little fire sesh with them and our kids, and his next door neighbor came over. He was a member of Congress. I talked about the VA bills, like [00:41:00] we're reaching out to his office now, um, to get them, um, up to speed and hopefully get their co-sponsorship for, uh, the two VA bills. Melissa Lavasani: So, I mean, it, the little conversations you have here are just as important as the big ones with the photo ops. So, um, it, it's, it's really like, you know, building up that momentum and, and finding that time where you can really strike and make something happen. Joe Moore: Mm-hmm. Yeah. Jay, anything to add there? Jay Kopelman: Yeah, I was just gonna say that, you know, I, I, I think the fervor is still there, right? Jay Kopelman: But real life happens. Melissa Lavasani: Yes, Jay Kopelman: yes. And gets in the way, right? So, Melissa Lavasani: yeah, Jay Kopelman: I, I can't imagine how many issues. Secretary Kennedy has every day much less the president. Like there's so many things that they are dealing with on a daily basis, right? It, we, we just have to work to be the squeaky wheel in, in the right way, right. Jay Kopelman: [00:42:00] With the, with the right information at the right time. Like just inundating one of these organizations with noise, it's then it be with Informa, it just becomes noise, right? It it, it doesn't help. So when we have things to say that are meaningful and impactful, we do, and Melissa does an amazing job of that. Jay Kopelman: But, you know, it, it takes time. You know, it's, you know, we're not, this is, this is like turning an aircraft carrier, not a ski boat. Melissa Lavasani: Yeah, Joe Moore: yeah, absolutely. Um, and. It's, it's understandably frustrating, I think for the public and the psychedelic public in particular because we see all this hope, you know, we continue to get frustrated at politics. It's nothing new, right? Um, and we, we wanna see more people get well immediately. [00:43:00] And I, I kind of, Jay from the veteran perspective, I do love the kind of loud voices like, you're making me go to Mexico for this. Joe Moore: I did that and you're making me leave the country for the thing that's gonna fix me. Like, no way. And barely a recognition that this is a valid treatment. You know, like, you know, that is complicated given how medicine is structured here domestically. But it's also, let's face the facts, like the drug war kind of prevented us from being able to do this research in the first place. Joe Moore: You know? Thanks Nixon. And like, how do we actually kind of correct course and say like, we need to spend appropriately on science here so we can heal our own people, including veterans and everybody really. It's a, it's a dire situation out there. Jay Kopelman: Yeah. It, it really is. Um, you know, we were talking briefly about addicts, right? Jay Kopelman: And you know, it's not sexy. People think of addicts as people who are weak-minded, [00:44:00] right? They don't have any self-control. Um, but, but look at, look at the opioid crisis, right? That Brian Hubbard was fighting against in Kentucky for all those years. That that was something that was given to the patient by a doctor that they then became dependent on, and a lot of people died from that. Jay Kopelman: And, and so you, you know, it's, I I don't think it's fair to just put all addicts in a box. Just like it's not fair to put all veterans in a box. Just like it's not fair for doctors, put all their patients in a box. We're individuals. We, we have individual needs. Our, our health is very individual. Like, I, I don't think I should be put in the same box as every other 66-year-old that my doctor sees. Jay Kopelman: It's not fair. [00:45:00] You know, if you, if you took my high school classmates and put us all in a photo, we're all gonna have different needs, right? Like, some look like they're 76, not 66. Some look like they're 56. Not like they're, we, we do things differently. We live our lives differently. And the same is true of addicts. Jay Kopelman: They come to addiction from different places. Not everybody decides they want to just try heroin at a party, and all of a sudden they're addicted. It happens in, in different ways, you know, and the whole fentanyl thing has been so daggum nefarious, right? You know, pushing fentanyl into marijuana. Jay Kopelman: Somebody's smoking a joint and all of a sudden they're addicted to fentanyl or they die. Melissa Lavasani: I think we're having a, Jay Kopelman: it's, it's just not fair to, to say everybody in this pot is the same, or everybody in this one is the same. We have [00:46:00] to look at it differently. Joe Moore: Yeah. I like to zoom one level out and kind of talk about, um, just how hurt we are as a country, as a world really, but as a country specifically, and how many people are out of work for so many. Joe Moore: Difficult reasons and away from their families for so many kind of tragic reasons. And if we can get people back to their families and back to work, a lot of these things start to self-correct, but we have to like have those interventions where we can heal folks and, and get them back. Um, yeah. And you know, everything from trauma, uh, in childhood, you know, adulthood, combat, whatever it is. Joe Moore: Like these things can put people on the sidelines. And Jay, to your point, like you get knee surgery and all of a sudden you're, you know, two years later you're on the hunt for Fentanyl daily. You know, that's tough. It's really tough. Carl Hart does a good job talking about this kind of addiction pipeline and [00:47:00] a few others do as well. Joe Moore: But it's just, you know, kind of putting it in a moral failure bucket. It's not great. I was chatting with somebody about, um, veterans, it's like you come back and you're like, what's gonna make me feel okay right now? And it's not always alcohol. Um, like this is the first thing that made me feel okay, because there's not great treatments and there's, there's a lot of improvements in this kind of like bringing people back from the field that needs to happen. Joe Moore: In my opinion. I, it seems to be shared by a lot of people, but yeah, there's, it's, it's, IGA is gonna be great. It's gonna be really important. I really can't wait for it to be at scale appropriately, but there's a lot of other things we need to fix too, um, so that we can just, you know, not have so many people we need to, you know, spend so much money healing. Joe Moore: Mm-hmm. Jay Kopelman: Yeah. You ahead with that. We don't need the president to sign an executive order to automatically legalize Ibogaine. Right. But it would be nice if he would reschedule it so that [00:48:00] then then researchers could do this research on a larger scale. You know, we could, we could now get some real data that would show the efficacy. Jay Kopelman: And it could be done in a safe environment, you know? And, and so that would be, do Joe Moore: you have any kind of figures, like, like, I've been talking about this for a while, Jay. Like, does it drop the cost a lot of doing research when we deschedule things? Jay Kopelman: I, I would imagine so, because it'll drop the cost of accessing the medicines that are being researched. Jay Kopelman: Right? You, you would have buy-in from more organizations. You know, you might even have a pharma company that comes into this, you know, look at j and j with the ketamine, right? They have, they have a nasal spray version of ketamine that's doing very well. I mean, it's probably their, their biggest revenue [00:49:00] provider for them right now. Jay Kopelman: And, and so. You know, you, it would certainly help and I think, I think it would lower costs of research to have something rescheduled rather than being schedule one. You know it, people are afraid to take chances when you're talking about Schedule one Melissa Lavasani: labs or they just don't have the money to research things that are on Schedule one. Melissa Lavasani: 'cause there's so much in an incredible amount of red tape that you have to go through and, and your facility has to be a certain way and how you contain those, uh, medicines. Oh, researching has to be in a specific container and it's just very cumbersome to research schedule one drugs. So absolutely the cost would go down. Melissa Lavasani: Um, but Joe Moore: yeah, absolutely. Less safes. Melissa Lavasani: Yeah. Joe Moore: Yes. Less uh, Melissa Lavasani: right. Joe Moore: Locked. Yeah. Um, it'll be really interesting when that happens. I'm gonna hold out faith. That we can see some [00:50:00] movement here. Um, because yeah, like why make healing more expensive than it needs to be? I think like that's potentially a protectionist move. Joe Moore: Like, I'm not, I'm not here yet, but, um, look at AbbVie's, uh, acquisition of the Gilgamesh ip. Mm-hmm. Like that's a really interesting move. I think it was $1.2 billion. Mm-hmm. So they're gonna wanna protect that investment. Um, and it's likely going to be an approved medication. Like, I don't, I don't see a world in which it's not an approved medication. Joe Moore: Um, you know, I don't know a timeline, I would say Jay Kopelman: yeah. Joe Moore: Less than six years, just given how much cash they've got. But who knows, like, I haven't followed it too closely. So, and that's an I bga derivative to be clear, everybody, um mm-hmm. If you're not, um, in, in the loop on that, which is hopeful, you know? Joe Moore: Mm-hmm. But I don't know what the efficacy is gonna be with that compared to Ibogaine and then we have to talk about the kind of proprietary molecule stuff. Um, there's like a whole bunch of things that are gonna go on here, and this is one of the reasons why I'm excited about. Federal involvement [00:51:00] because we might actually be able to have some sort of centralized manufacturer, um, or at least the VA could license three or four generic manufacturers per for instance, and that way prices aren't gonna be, you know, eight grand a dose or whatever. Joe Moore: You know, it's, Jay Kopelman: well, I think it's a very exciting time in the space. You know, I, I think that there's the opportunity for innovation. There is the opportunity for collaboration. There's the opportunity for, you know, long-term healing at a very low cost. You know, that we, we have the highest healthcare cost per capita in the world right here in the us. Jay Kopelman: And, and yet we are not the number one health system in the world. So to me, that doesn't add up. So we need to figure out a way to start. Bringing costs down for a lot of people and [00:52:00] at the same time increasing, increasing outcomes. Joe Moore: Absolutely. Yeah. There's a lot of possible outcome improvements here and, and you know, everything from relapse rates, like we hear often about people leaving a clinic and they go and overdose when they get home. Tragically, too common. I think there's everything from, you know, I'm Jay, I'm involved in an organization called the Psychedelics and Pain Association. Joe Moore: We look at chronic pain very seriously, and IGA is something we are really interested in. And if. We could have better, you know, research, there better outcome measures there. Um, you know, perhaps we can have less people on opioids to begin with from chronic pain conditions. Um, Jay Kopelman: yeah, I, I might be due for another Ibogaine journey then, because I deal with chronic pain from Jiujitsu, but, Joe Moore: oh gosh, let's Jay Kopelman: talk Joe Moore: later. Jay Kopelman: That's self inflicted. Some people would say take a month off, but Melissa Lavasani: yeah, Jay Kopelman: I'm [00:53:00] not, I'm not that smart. Joe Moore: Yeah. Um, but you know, this, uh, yeah, this whole thing is gonna be really interesting to see how it plays out. I'm endlessly hopeful pull because I'm still here. Right. I, I've been at this for almost 10 years now, very publicly, and I think we are seeing a lot of movement. Joe Moore: It's not always what we actually wanna see, but it is movement nonetheless. You know, how many people are writing on this now than there were before? Right. You know, we, we have people in New York Times writing somewhat regularly about psychedelics and. Even international media is covering it. What do we have legalization in Australia somewhat recently for psilocybin and MDMA, Czech Republic. Joe Moore: I think Germany made some moves recently. Mm-hmm. Um, really interesting to see how this is gonna just keep shifting. Um Jay Kopelman: mm-hmm. Joe Moore: And I think there's no way that we're not gonna have prescription psychedelics in three years in the United States. It pro probably more like a [00:54:00] year and a half. I don't know. Do you, are you all taking odds? Melissa Lavasani: Yeah. I mean, I think Jay Kopelman: I, I gotta check Cal sheet, see what they're saying. Melissa Lavasani: I think it's safe to say, I mean, this could even come potentially the end of this year, I think, but definitely by the end of 2027, there's gonna be at least one psychedelic that's FDA approved. Joe Moore: Yeah. Yeah. Melissa Lavasani: If you're not counting Ketamine. Joe Moore: Right. Jay Kopelman: I, I mean, I mean it mm-hmm. It, it doesn't make sense that it. Shouldn't be or wouldn't be. Right. The, we've seen the benefits. Mm-hmm. We know what they are. It's at a very low cost, but you have to keep in mind that these things, they need to be done with the right set setting and container. Right. And, and gotta be able to provide that environment. Jay Kopelman: So, but I would, I would love, like I said, I'd love to work myself out of a job here and see this happen, not just for our veterans, [00:55:00] but for everybody. Joe Moore: Mm-hmm. Um, so Melissa, is there a way people can get involved or follow PMC or how can they support your work at PMC? Melissa Lavasani: Yeah, I mean, follow us in social media. Melissa Lavasani: Um, our two biggest platforms are LinkedIn and Instagram. Um, I'm bringing my newsletter back because I'm realizing, um, you know, there is a big gap in, in kind of like the knowledge of Washington DC just in general. What's happening here, and I think, you know, part of PC's value is that we're, we are plugged into conversations that are being had, um, here in the city. Melissa Lavasani: And, you know, we do get a little insight. Um, and I think that that would really quiet a lot of, you know, the, a lot of noise that, um, exists in the, our ecosystem. If, if people just had some clarity on like, what's actually happening or happening here and what are the opportunities and, [00:56:00] um, where do we need more reinforcement? Melissa Lavasani: Um, and, and also, you know, as we're putting together public education campaign, you know. My, like, if I could get everything I wanted like that, that campaign would be this like multi-stakeholder collaborative effort, right? Where we're covering all the ground that we need to cover. We're talking to the patient groups, we're talking to traditional mental health organizations, we're talking to the medical community, we're talking to the general population. Melissa Lavasani: I think that's like another area that we, we just seem to be, um, lacking some effort in. And, you know, ultimately the veteran story's always super compelling. It pulls on your heartstrings. These are our heroes, um, of our country. Like that, that is, that is meaningful. But a lot of the veteran population is small and we need the, like a, the just.[00:57:00] Melissa Lavasani: Basic American living in middle America, um, understanding what psychedelics are so that in, in, in presenting to them the stories that they can relate to, um, because that's how you activate the public and you activate the public and you get them to see what's happening in these clinical trials, what the data's been saying, what the opportunities are with psychedelics, and then they start calling their members of Congress and saying, Hey, there is this. Melissa Lavasani: Bill sitting in Congress and why haven't you signed onto it? And that political pressure, uh, when used the right way can be really powerful. So, um, I think, you know, now we're at this really amazing moment where we have a good amount of congressional offices that are familiar enough with psychedelics that they're willing to move on it. Melissa Lavasani: Um, there's another larger group, uh, that is familiar with psychedelics and will assist and co-sponsor legislation, but there's still so many offices that we haven't been able to get to just 'cause like we don't have all the time in the world and all the manpower in the world to [00:58:00] do it. But, you know, that is one avenue is like the advocates can speak to the, the lawmakers, the experts speak to the lawmakers, and we not, we want the public engaged in this, you know, ultimately, like that's. Melissa Lavasani: Like the best form of harm reduction is having an informed public. So we are not, they're not seeing these media headlines of like, oh, this miracle cure that, um, saved my family. It's like, yes, that can happen psychedelics. I mean, person speaking personally, psychedelics did save my family. But what you miss out of that story is the incredible amount of work I put into myself and put into my mental health to this day to maintain, um, like myself, my, my own agency and like be the parent that I wanna be and be the spouse that I wanna be. Melissa Lavasani: So, um, we, we need to continue to share these stories and we need to continue to collaborate to get this message out because we're all, we're all in the same boat right now. We all want the same things. We want patients to have safe and [00:59:00] affordable access to psychedelic assisted care. Um, and, uh. We're just in the beginning here, so, um, sign up for our newsletter and we can sign up on our website and then follow us on social media. Melissa Lavasani: And, um, I anticipate more and more events, um, happening with PMC and hopefully we can scale up some of these events to be much more public facing, um, as this issue grows. So, um, I'm really excited about the future and I'm, I've been enjoying this partnership with Mission Within. Jay is such a professional and, and it really shows up when he needs to show up and, um, I look forward to more of that in the future. Joe Moore: Fantastic. And Jay, how can people follow along and support mission within Foundation? Jay Kopelman: Yeah, again, social media is gonna be a good way to do that. So we, we are also pretty heavily engaged on LinkedIn and on Instagram. Um, I do [01:00:00] share, uh, a bit of my own stuff as well. On social media. So we have social media pages for Mission within Foundation, and we have a LinkedIn page for mission within foundation. Jay Kopelman: I have my own profiles on both of those as well where people can follow along. Um, one of the other things you know that would probably help get more attention for this is if the general public was more aware of the numbers of professional athletes who are also now pursuing. I began specifically to help treat their traumatic brain injuries and the chronic traumatic encephalopathy that they've, uh, suffered as a result of their time in professional sports or even college sports. Jay Kopelman: And, you know. I people worship these athletes, and I [01:01:00] think that if more of them, like Robert Gall, were more outspoken about these treatments and the healing properties that they've provided them, that it would get even more attention. Um, I think though what Melissa said, you know, I don't wanna parrot anything she just said because she said it perfectly Right. Jay Kopelman: And I'd just be speaking to hear myself talk. Um, but being collaborative the way that we are with PMC and with Melissa is I think, the way to move the needle on this overall. And like she said, if she could get more groups involved in, in these discussions, it would, it would do wonders for us. Joe Moore: Well, thank you both so much for your hard work out there. I always appreciate it when people are showing up and doing this important, [01:02:00] sometimes boring and tedious, but nevertheless sometimes, sometimes exciting work. And um, so yeah, just thank you both and thank you both for showing up here to psychedelics today to join us and I hope we can continue to support you all in the future. Jay Kopelman: Thank you, Joe. Thank you, Joe. It's a pleasure being with you today and with Melissa, of course, always Melissa Lavasani: appreciate the time and space. Joe Moore: Thanks.  

Ohio State football kicks off its spring schedule in less than three weeks, and one of the areas that will get the most attention is the new look safety unit. Former Duke safety Terry Moore, and Florida State transfer Earl Little are joining Matt Guerreri's position group, along with returning starter Jaylan McClain. But can talented young players like Blaine Bradford, Leroy Roker, or Deshawn Stewart make a push for playing time, too?In this episode of the Buckeyes TomOrrow Morning podcast, Tony Gerdeman of BuckeyeHuddle.com joins host Tom Orr to discuss that and more.

What if those “self sabotaging” behaviors you are trying to break, are coming from a part of you the is desperately seeking safety. If you keep procrastinating, strategy hopping, overcomplicating, or pulling back right when things start working, it's easy to default to self judgement. But calling these actions “self sabotage” just further perpetuates the war with ourself. You are not an evil saboteur of your own success. You are a human seeking safety.In this episode, I unpack the process of translating all the internal healing work you've been doing into real behavioral change that moves you forward.You'll discover: The 4 step rewiring process to break free of these “self sabotage” patterns.When to do the “practical work” and when to do the “deeper inner work”. How to identify the one action you need to focus on to shake off the stuck-ness.Press play to stop fighting yourself — and start building momentum from a place of safety and alignment! Join the FREE 3 Day Workshop to Move Like a Leader.Stop hesitating. Stop shrinking. Start turning your ideas into action. https://spiritually-ambitious.kit.com/move This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit 100khealer.substack.com/subscribe

Anthony and Alex discuss Caleb Downs and react to John Harbaugh's interview on the Mike Francesa Podcast. Harbaugh didn't hold back when asked about Ohio State's Caleb Downs, calling him a "potential future Hall of Fame safety" and emphasizing a "Best Player Available" philosophy for the 2026 NFL Draft. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, I'm joined by Dani Lebovitz, co-author of Food Positivity, to explore why emotional safety at the table matters more than food rules—and what actually helps kids build trust with eating.

Solo Travel Tips and Advice Many of us are afraid to travel solo.  On today's show we delve in to how to travel solo safely, plus the pros and cons of solo travel.  I interview three expert solo travelers to get their best advice and encourangement.  Visit the website to delve deeper into the pros and cons of traveling solo safely. COMPLETE SHOW NOTES  See important links for planning your adventure, photos, videos and more cool info about today's show. Get FREE Travel Planners, Checklists and Packing Lists for ATA adventures (and each month you will get an email from Kit with links to all future Travel Planners (no spam promise!).  Get the monthly newsletter here. CONTACT KIT Resources  RECOMMENDED TOUR COMPANIES ******* EMAIL ME FOR PROMO DISCOUNT CODES***** Saily Affordable eSIM Overseas Mobile Phone Plans - No need to insert a physical SIM card when you travel.  Buy just the data you need to avoid expensive roaming charges.  Use Promo Code SPECIAL5 to save 5% Travel Insurance:  Quickly and easily compare rates and policies from different companies - no need to give any identifying information unless you decide to buy!  The best way to find the right policy for your adventures.  High Altitude Travel Insurance Most insurance policies do NOT cover high altitude adventures.  Check out Rise & Shield for your next mega adventure! Train For Your Adventure  Ask Becki at Trailblazer Wellness to customize an at home, online personal training program for your upcoming adventure using whatever equipment you already have!  You'll get phone consultations, instruction videos and a plan to give you the best chance of success.  Becki offers a FREE initial phone consultation to see if you are a good fit.  AND she offers ATA listeners a 10% discount! Buy Me a Beer Want to support the program?  You can always buy me a coffee or beer - thanks! Tinggly:  Give Gift Experiences instead of stuff (plus your loved one gets to choose)! Promo Code ACTIVETRAVEL saves up up to 20% Amazon Kit's Picks   Please use my Amazon link to access your Amazon account.  Even if you don't purchase any of my recommendations, I get credit for anything you DO purchase - at no additional cost to you, you'll be helping to support the show and keeping it AD FREE:) SUBSCRIBE to Active Travel Adventures (fantastic adventure destinations) Episodes Mentioned in this Show: Galapagos Dolomites Kilimanjaro Part I Kilimanjaro Part II Machu Picchu Annapurna Travel Safety Tips Join the Active Travel Adventures Facebook Group Follow ATA on Instagram Follow ATA on Pinterest Solo Adventure Travel Transcript We're going solo. That's right. Even if you have a partner, I want you to read this blog post because there are definite advantages and challenges to traveling solo. Even if you think, "There is no way I would ever travel solo, " please read on with an open mind. You might change your mind. I'll be interviewing three solo travelers about the challenges and joys of traveling solo. Since I usually travel solo myself, you'll hear my two cents' worth as well. It's a great show. Even if you think, "No way, I could never travel solo, " I beg you, please read on and see if you don't change your mind. If you're like me, you don't want to live an ordinary life. You want to live a kick-ass life, and one way to do so is to add adventure travel to your life. I find adventure travel brings out the best in me. It challenges me, it encourages me, it enlightens me, and it inspires me to lead a bigger life. On this program, you'll learn about amazing adventures from around the world plus get the tools and information you need so you can do these adventures with confidence. You'll come home feeling empowered and with amazing memories and stories you can relive forever. Don't worry—the bar is such that my relatively fit 58-year-old body, particularly with some training, can do these adventures, and you can too. This episode is a roundup episode. I've got three guests that I will be interviewing separately about their experiences with solo travel. Our first guest is Jackie Norris, who we met on one of our episodes. She is the host of Traveling Jackie and The Budget-Minded Traveler and has been traveling solo for a long time. She has a ton of insights to share with us. When I interviewed her in Quebec, I asked her casually about solo travel. We got so engrossed in it that I decided to take that section of our interview and add it to this solo episode. Our other guests are Monica and Jason. I'll let them introduce themselves. Let's start with my interview with Jackie. Jackie Norris Interview Kit: Jackie, why do you travel solo? Jackie: The reason I do solo travel is that I'm solo. I don't let that stop me. For years and years, a lot of people struggle with the idea of getting out on their own. It's a necessity for me. It's what I have to do, and so I do it. I never thought I would enjoy it, but I do love it now. You have to get to a point where you're comfortable with it. I'd already been traveling for a number of years by the time I went fully solo nomadic a few years ago. Even after that much time of being comfortable traveling, it was weird to be on my own all the time.For the cons, you are by yourself. All of those travel decisions are made only by you. Even where you're going to eat for breakfast or whether you're going to get a beer in the afternoon—everything is solely up to you. There's no one you can confer with. That also happens to be one of the advantages. Sometimes it depends on which perspective you have. Maybe it depends on the day. Sometimes it's amazing, and sometimes you wish there was someone there. Loneliness is a real thing. I have written about that before, and most solo travelers will face real loneliness. It's not just the point of being solo in a place—it's feeling alone. There's a big difference, and that can get to you if it lasts a while. I traveled for months at a time, and it can get draining to be alone. At the same time, this is where I am in my life, and this is what I'm signing up for. This is also my work, and this is what I'm choosing to do. It's part of the territory if you look at it that way. The freedom that solo travel provides is unmatched. There is a feeling that comes with being on your own in some far-flung corner of the planet, completely left to yourself and your own thoughts. What you want to do for the day—everything is your will. It is the most freeing feeling ever. It's incredible. You can do whatever you want. There are definitely pros and cons of solo travel. I always encourage people to at least try it out because you get to know yourself very quickly. Even if you think you know yourself, you don't—not until you solo travel. You see what you're capable of and what your weaknesses are. It's an incredible tool for life to solo travel. Everyone should do it at least once. Kit: You had a quote in The Budget-Minded Traveler episode number 63 that I loved: "Lose yourself until you find yourself. " Could you talk a little bit about that? Jackie: It gave me chills when you read it. That came from a piece that I wrote on my Traveling Jackie blog. It was when I decided to leave everything behind and go out on my own to travel the world solo for real for the first time. This was many years after having traveled a whole bunch already and studying abroad and all that. This was different because I had a relationship, I had a house, and I had all these things. I felt very lost at times because I had to recreate what my life looked like. That was my moment to decide what my new normal was going to be going forward. I did lose part of myself there in a good way though. It's like you have to go see what the world has for you and then figure out what you look like in that new normal. Figure out what the path forward is in this new reality that you've created. That's at least how it applied to me. It depends on what your situation is and why you're choosing to solo travel. So much about experience outwardly when you travel has to do with what's going on inside. That was my experience at the time. I totally went out and lost myself until I started to rebuild and find what it meant to start over. Kit: It's obvious that travel in general and solo travel in particular changed your life.Jackie: I'm grateful for that because I feel so much surer of who I am. I'm so much stronger now. I have so much more confidence. These are the things that come with being on your own for so long in a place. It's not being on your own at home where you're comfortable and you know the name of the store owner down the street. Everything is different—foreign languages, foreign currency, borders, flights, hotels. Everything is a challenge. When you add that element to being completely on your own for a long time, maybe for the first time, it changes everything. Your personal growth is expedited more than anything. "The world outside of your comfort zone is not a place to invite fear. It's a place to invite curiosity. " Kit: Since I lost my husband, I've been traveling solo. The question I get over and over again is about safety. How do you deal with safety concerns? Jackie: Are you not afraid of those things at home? Bad things can happen anywhere. It doesn't matter where you are. In fact, the U.S. these days could be less safe than a lot of other places I travel. I don't dwell on that stuff. I have some tricks up my sleeve to make sure I'm safe and my belongings are safe. I pay attention. Common sense is your best defense. Don't leave your common sense behind when you walk out the door. Go explore the world outside your comfort zone. It's not about fear and safety—it's about adventure, life, growth, people, connection, culture, food, language, activity, and beauty. That outweighs the fear. Monica Aranguren Interview Kit: Can you introduce yourself and tell us your age? Monica: I'm Monica Aranguren, and I am 58 years old. Kit: How did you get into adventure travel? Monica: Quite honestly, I found myself single again around 2007 or 2008. I started hiking on my own. When I turned 50, I decided I wanted to do something bigger and planned a trip to New Zealand. Kit: Was that your first adventure trip? Monica: Yes. I didn't want to leave adventure behind. Kit: How did you make the mindset shift to go on your own?Monica: so I went. I've been independent all my life. I wasn't waiting for life to happen to me. I wanted to see these places, Kit: Did you go solo or with a company? Monica: The New Zealand trip was with Active Adventures. I've made many trips like that since. Solo travel lets you expand a little bit more in getting out of the box. You meet people you wouldn't meet otherwise. I don't really see many cons—except I always choose a single room so I can sleep! I've always felt safe. On guided trips, you're surrounded by your group. On self-guided trips, I had GPS, instructions, and 24-hour support. I always felt supported. Loneliness happens occasionally, especially on self-guided hikes, but overall it hasn't been an issue. It empowers me. When I get back, I think, "I did that. " That confidence carries into real life. Jason Waitkins Interview Kit: Can you introduce yourself? Jason: My name is Jason Waitkins, and I am 37. Kit: How did you get into adventure travel? Jason: My first trip was in 2003 to New Zealand. I wanted to hike. That was the driver. I grew up next to the Appalachian Trail and hiked sections near my home in the Hudson Valley. Solo travel is easier to coordinate. I go when I want. If no one else wants to go, I go anyway. Safety is always a consideration. I research countries, crime, and logistics. Awareness is key. I use common sense, just like I would anywhere else. I once got injured hiking solo in Acadia National Park and had to be carried out. That experience reinforced the value of group travel for certain adventures. Using tour companies removes logistical stress and adds safety. Solo travel hasn't dramatically changed who I am, but it keeps me going. I want to keep visiting places and hiking everywhere I can. Final Thoughts and Solo Travel RulesWhen I travel solo, I make rules for myself: ● ● ● ● ● ● ● ● I know where I'm staying by noon I arrive before dark I watch my food and drink I'm cautious of overly friendly strangers I use official taxis or rideshare services I trust my instincts I always have an exit plan Someone knows where I'm going If you're not sure solo travel is for you, try a weekend trip. Then try a week. Build confidence gradually. In all my travels, I've never had a serious incident. You heard the same from our guests. If you want to help shape future adventures, reach out to me by email or on social media. Until next time, this is Kit Parks—adventure on. (C) Active Travel Adventures, LLC - All Rights Reserved

In Michigan, prosecutors play bodycam at the trial of Dale Warner, a farmer on trial for allegedly murdering his wife and concealing her body in a fertilizer tank. In Miami, twenty years after Bryan Pata, the star defensive lineman on the University of Miami football team, was gunned down on the way home from practice, his teammate goes on trial for his murder. In Dateline Round Up, verdicts in the Paul Caneiro and Tara Baker trials. Plus, NBC News' Vicky Nguyen shares some tips on stadium safety.Nancy Guthrie Tipline: 1-800-CALL-FBI (1-800-225-5324)Nancy Guthrie images: https://www.fbi.gov/wanted/kidnap/nancy-guthrieFind out more about the cases covered each week here: www.datelinetruecrimeweekly.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Longevity isn't just workouts, supplements, and recovery tools, it starts with nervous system health. In this episode, Dr. Aimie Apigian explains what trauma actually is (not a label, but a measurable physiological response), how the body shifts from stress into overwhelm, and why “pushing through” often turns into years of avoidance, numbing, and hidden internal strain.She breaks down the biology behind the trauma response, including the role of adrenaline, cortisol timing, and how mitochondrial capacity influences resilience. You'll also learn her practical, body-based approach to creating “safe enough” in real time, plus the three phases of healing: safety, support, and expansion, so you don't stay stuck avoiding triggers forever.In this conversation:Stress vs trauma response (and what changes physiologically)Why adrenaline drives the response and cortisol arrives laterHow the body stores trauma as patterns, not just memoriesThe 3 nervous system states and the thoughts they generateA simple somatic exercise to build safety in the bodyWhy devices/meds can be bridges, not the destinationUsing biomarkers + wearables without fooling yourselfWhy modern media can create vicarious traumaJoin the most comprehensive *female-specific community for health and longevity optimization.* After over a decade dedicated to human performance and women's health, I created this space to share everything you need to know to optimize health and lifespan. Inside, you'll get access to exclusive protocols, live Q&As, the latest female longevity science, and a private, supportive community of like-minded women.https://kayla-barnes-lentz.circle.so/checkout/become-a-memberConnect with Kayla:Instagram: https://www.instagram.com/kaylabarnes/TikTok: https://www.tiktok.com/@femalelongevityTwitter:https://x.com/femalelongevityWebsite:https://www.kaylabarnes.com/YouTube: www.youtube.com/@KaylaBarnesLentzSpotify:https://open.spotify.com/show/4OLWWn22...Apple: https://podcasts.apple.com/us/podcast...Follow Her Female Protocol: https://www.protocol.kaylabarnes.comLearn more about Dr. Aimie Apigian, MD:Instagram: https://www.instagram.com/draimie/YouTube: https://www.youtube.com/c/DrAimieApigianWebsite: https://www.biologyoftrauma.com/Order her Book “The Biology of Trauma”: https://www.biologyoftrauma.com/book

⛔ In this episode of Vanilla Swingers — Apple's #1 ranked swinger podcast — we're saying it out loud: We hate vetting.

Homeschooling is growing here and across the country with little oversight. What advocates say needs to happen to eusnre kids are learning and safe. Plus, what's behind the Suns' surprising success so far this season.

Episode Sponsor - Airia.comThe AI Compiler Debate: Anthropic's Claude-generated C compiler has sparked controversy; while marketed as a milestone, hands-on testing reveals it is fragile, significantly slower than traditional compilers (like GCC), and heavily reliant on human-written code.The SaaS "Death Spiral": The traditional "per-seat" licensing model for software is under threat as AI agents begin to do the work of multiple people, leading to massive market cap losses for giants like Salesforce and Adobe.Safety and Ethics Concerns: Beyond the "doomerism" of upcoming AI documentaries, real-world concerns are mounting, including lawsuits against AI-powered surgical tools (TruDi Navigation System) and Meta's patent for AI that replicates the online behavior of deceased users.Innovation vs. "Vibe Coding": There is a growing shift toward "vibe coding"—prioritizing the speed of AI generation over long-term stability—which critics argue creates bloated software and significant technical debt.The Rise of Autonomous Models: Intelligence is becoming a commodity through high-performance open-weight models (like Qwen and MiniMax), pushing the industry away from human-centric dashboards toward autonomous orchestration.@trikcode@rushicrypto

Dr. Eddie Capparucci and Tami explore the uncomfortable truths of emotional regulation, the importance of sitting with emotional discomfort, and realistic expectations for betrayal addicts and their partners to see improvements in their relationship. They then answer listener questions about  emotional regulation techniques, timeframes, and the motivation behind seeking to be an emotionally regulated partner in a relationship.    TAKEAWAYS: [1:33] The hard truth of staying emotionally present.  [4:34] Roadblocks to developing emotional leadership.  [7:08] What emotional leadership isn't.  [10:29] What emotional leadership is.  [18:30] Your partner is seeking safety, not explanations. [20:33] Dialogue for emotionally stable conversations.  [22:35] The role of healthy conflict in healing.  [28:19] "You are asking a lot of the betrayed partner."  [33:32] The person in pain and grief never gets to take a timeout from the nightmare. Why should their partner?  [35:17] Is this a slip or relapse?  [38:36] How can I better manage my emotions in the moment?  [40:20] How long should recovery work take?  [43:02] How can I correct after I become disregulated?  [45:43] How long will it take to feel confident and see results in my relationship?  [47:40] My partner ran away, how long should I give him to process?  [49:58] Body language recommendations.  [53:47] How do I know if emotional regulation techniques are working for me?    RESOURCES: Seekingintegrity.com Email Tami: Tami@Seekingintegrity.com Sexandrelationshiphealing.com Intherooms.com Out of the Doghouse: A Step-by-Step Relationship-Saving Guide for Men Caught Cheating, by Robert Weiss Prodependence: Moving Beyond Codependency, by Robert Weiss Sex Addiction 101: A Basic Guide to Healing from Sex, Porn, and Love Addiction, by Robert Weiss Cruise Control: Understanding Sex Addiction in Gay Men, by Robert Weiss Seeking Integrity Podcasts are produced in partnership with Podfly Productions.    QUOTES "You cannot establish emotional leadership if you can't emotionally regulate yourself."  "Emotional leadership is not about winning. It's about the way you handle emotional distress when things become uncomfortable."  "Safety, not explanations, is what your partner's nervous system is seeking in order to regulate."  "You can be factually correct and absent at the same time."  "Demonstrating emotional leadership is not a one-time performance."  

Hour 2 with Bob Pompeani and Joe Starkey: 80% of Bob's Twitter poll respondents said they do not want to see 3-on-3 overtime in the NHL playoffs. Should we be concerned about Paul Skenes in the World Baseball Classic? Steelers Hall of Honor safety Mike Wagner has passed away at age 76. Wagner was a great safety on the 1970s Steelers. We remember the 1980 Miracle on Ice and the great Netflix documentary: The Boys of 80.

Steelers Hall of Honor safety Mike Wagner has passed away at age 76. Wagner was a great safety on the 1970s Steelers. Joe thinks Wagner was so underrated. We remember the 1980 Miracle on Ice and the great Netflix documentary: The Boys of 80.

IntroQuestion of the WeekAyyyye yuuungIBM vs NvidiaLower minimum wage for teenagersSmug Dude's Kettle ChipsRing CamerasAI usage onn Ring camerasSharing date with ICEICE spends 38.3 billion Over 100,000 new beds for detaineesPay for play contractsWellington Park - Dallas Pokornik

“That's the thing that's maybe getting lost in some of the fear mongering around it is that, it's not the easy way out. It doesn't mean that you don't have to do the work. It means that when you do the work, the work actually makes the difference.” —Aja BeckettFood noise can sit in the back of the mind all day, from planning the next meal at breakfast to carrying quiet shame after every snack. In a culture that moralizes weight and labels bodies as failures, real medical treatment for obesity often gets buried under hot takes about shortcuts and cheating. This conversation brings the lived reality of GLP-1 medication into the light, with honesty about both relief and responsibility.Aja Beckett shares decades of struggling with obesity, endless diets, and that constant mental hum around food, then walks through how starting a GLP-1 weight loss drug shifted cravings, energy, and hope. Her experience led to building Shotsy, a companion app that tracks doses, side effects, and progress for people on GLP-1 medications.Press play to hear how this new class of medications is reshaping daily life, mindset, and digital tools around obesity care, including:What GLP-1 drugs like Ozempic and Wegovy actually do in the bodyThe difference between “food noise” and genuine hungerWhy weight loss drugs are not a lazy shortcut or moral failureHow mental health, cravings, and compulsive behaviors often change on GLP-1sThe cost, access, and safety concerns around weight loss injections and pillsHow a GLP-1 tracking app grew from one person's spreadsheet into a fast-growing productWhat long-term obesity treatment and maintenance can realistically look likeConnect with Heather:WebsiteLinkedInInstagramFacebookYouTubeEpisode Highlights:01:11 Meet Aja Beckett: Founder of Shotsy & GLP‑1 Success Story04:43 Discovering Ozempic & a Difficult Doctor's Visit07:35 Beyond Weight Loss: GLP‑1, Mental Health & Addictive Behaviors10:43 Losing 90 Pounds: From Obesity to Healthy BMI13:30 Do You Still Have to Eat Healthy & Work Out on GLP‑1?16:21 When the Food Noise Stops: First Days on GLP‑119:37 Super Bowl Snacks, Portion Control & Balanced Indulgence22:12 Body Dysmorphia in Bigger & Smaller Bodies26:00 Safety vs Affordability: Regulation, Shortages & DIY Risks32:09 Introducing Shotsy: The GLP‑1 Companion App Idea39:50 Why Tools Like Shotsy Matter for Accountability & Tracking42:21 GLP‑1 Isn't the “Easy Way Out”: Doing the Work & Seeing ResultsResources:

Why You Can't "Force" Your Healing: From Survival to Safety Are you trying too hard to heal? In the final part of my healing journey trilogy, I reveal a counterintuitive truth: the harder we push, the harder it is for our bodies to recover. Many of us treat healing like a discipline, controlling our diets, pushing through fatigue and demanding results but your body cannot heal while it is in survival mode.In this episode, we explore:The Nervous System: Why safety is a feeling, not a thought.The Wisdom of Symptoms: Decoding the messages behind eczema, thyroid issues, and adrenal burnout.Depression as "Deep Rest": Re-framing mental health struggles as a biological cry for stillness.The Power of Allowing: Shifting from "doing" to "being" to turn off your body's red alert.If you've been your own harshest critic, it's time to stop pushing and start listening. Learn how to cooperate with your body and provide the safety it needs to finally heal.Key Information 00:18 — The Healing Trilogy: Reflecting on the journey from where I was to where I am now.00:39 — The Myth of "Effort": Why trying harder and being more disciplined can actually prevent healing.01:43 — Survival vs. Safety: Understanding that the body heals only when it no longer feels the need to protect itself.02:30 — The Nervous System: Safety is a feeling in the body, not a scientific concept or a logical thought.03:22 — Rest is Not Lazy: Re-framing rest as a necessary form of self-care and a signal of safety to the brain.04:58 — Listening to Body Wisdom: Shifting from looking for external solutions to listening to internal messages.05:16 — Decoding Symptoms: Eczema, Adrenal Fatigue, Thyroid07:05 — Depression as "Deep Rest": A powerful re-framing of depression as the body's desperate cry for stillness.07:46 — Cooperating with the Body: Learning to treat yourself with the same kindness you offer others.08:35 — A Message for Those Still Healing: Why not being "healed yet" isn't a failure, but a learning process for your body.Who am I?Sarah Dawkins is a passionate Holistic Health and Healing Coach, international speaker and author of Heal Yourself. She's also a multi-award-winning entrepreneur and the award-winning host of the uplifting podcast Mind Body Medicine for Self Healers with Sarah Dawkins.With over 20 years' experience as a Registered Nurse, Sarah combines her deep understanding of conventional medicine with her own powerful self-healing journey to create a truly integrative approach. Having overcome multiple chronic health challenges herself, she now supports others in uncovering and addressing the root causes of their symptoms, helping them restore balance, reclaim their energy and create lasting, vibrant wellness.www.sarahdawkins.com#learningtips #selfawarenessmatters #selfhealing #healingjourney #mindbodyconnection

In this episode of the On Track Podcast, President & CEO Eric Ritchie is joined by Safety Specialist Tony Adams, Safety Manager James Joiner, and Safety Director Cam Haggar in the Flywheel Studio to talk about setting a positive tone for safety in 2026, with a focus on CARE for the well-being of every employee-owner. The group shares how Sargent's safety training continues to evolve, driven by real jobsite needs. They emphasize that training only works when it is paired with strong field mentorship, and they reinforce a clear message that every employee-owner has stop work authority, no matter their role or tenure.If you liked this week's episode and are interested in becoming an Employee-Owner at Sargent, please visit our careers page on the Sargent website. https://sargent.us/apply/If you have an episode suggestion, please send your idea to:sbennage@sargent.us

Black History Month isn't supposed to be a highlight reel of the same five names. It's supposed to be receipts. And today I'm putting you on one most people have never heard of: Annie Turnbo Malone.Before “personal brand.” Before “women in business” panels. Before folks started acting like community was a hashtag, Annie built Poro College and used business like a real tool: training, jobs, pride, and a whole ecosystem for Black women to earn and grow.This episode is about the difference between a hustle and infrastructure. Annie didn't just sell a product. She built a system and a hub. Political events. Community events. Support. Safety. A place that meant something.And if you're a business owner right now trying to hold everything together, this is your reminder: stability is power. Clarity and community aren't “soft.” They're survival skills.Watch on YouTube: https://youtu.be/fIyt0YxA-HAAs always we ask you to comment, DM, whatever it takes to have a conversation to help you take the next step in your journey, reach out on any platform!Twitter, FaceBook, Instagram, Tiktok, LinkedinDISCLOSURE: Awards and rankings by third parties are not indicative of future performance or client investment success. Past performance does not guarantee future results. All investment strategies carry profit/loss potential and cannot eliminate investment risks. Information discussed may not reflect current positions/recommendations. While believed accurate, Black Mammoth does not guarantee information accuracy. This broadcast is not a solicitation for securities transactions or personalized investment advice. Tax/estate planning information is general - consult professionals for specific situations. Full disclosures at www.blackmammoth.com.

What does it look like when passion, community, and craftsmanship come together to build more than a business? In this episode of The Trades Podcast, hosts Jeff Mudd and Danny Torres sit down with Talena Handley, CEO of Girly Garage, to explore how a single idea can grow into a vibrant community built around cars, confidence, and connection.In this episode, Jeff and Danny sit down with Talena Handley, CEO of Girly Garage, a community-first company dedicated to making automotive education accessible and empowering. Talena discusses how Girly Garage was built around the idea that anyone can learn to work on vehicles confidently when given the right instruction, environment, and support.The conversation dives into the importance of inclusive training, breaking down barriers in male-dominated industries, and using community engagement as a foundation for growth. Talena also shares insights on leadership, building events that inspire connection, and nurturing a loyal audience that feels ownership in the brand's mission.Resources & MentionsGirly Garage Website: https://www.girliegarage.com/About Girly Garage: https://www.girliegarage.com/aboutThe Trades Podcast: https://www.thetradespodcast.comWhat You Will LearnHow inclusive education strengthens confidence and skillsWhy community matters in trade and automotive fieldsHow Girly Garage expanded from local meetups to a thriving brandThe role of leadership in fostering inclusivity and belongingPractical insights for building community-driven business growth Chapters00:00 Introduction to The Trades Podcast01:00 Meet Talayna Handley: Founder of Girly Garage03:31 The Birth of Girly Garage08:17 Empowering Through Education11:31 The Importance of Automotive Knowledge12:54 Expanding Girly Garage's Reach15:12 The Gender Gap in Automotive Mechanics18:50 Safety and Education in Automotive Training20:36 The Future of Trades and Education24:28 Challenges Facing Small Businesses27:21 The Role of Girly Garage in Automotive Education30:56 Career Paths in Automotive Industry35:08 Staying Grounded in the Trades37:30 The Vision for Girly Garage's Future  About The Trades PodcastWebsitehttps://www.thetradespodcast.comHosted byJeff Mudd and Danny TorresThe Trades Podcast features real conversations with business owners, trades leaders, and industry innovators making an impact in the skilled trades community. Support the Trades MovementIf this episode inspires you, share it with someone in the trades or anyone thinking about starting a home-services business. Like, comment, and subscribe to help more people discover these conversations.

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3463: Darrow Kirkpatrick explores the hidden risks of managing wealth in a digital age, from rare system failures to physical disasters that could wipe out essential documents. He offers clear, actionable strategies to keep your finances resilient like diversifying accounts, securing digital backups, and protecting vital records at home and in the cloud. Read along with the original article(s) here: https://www.caniretireyet.com/protecting-your-assets-in-a-digital-world/ Quotes to ponder: "The simplest way to protect yourself against computer glitches may be to diversify your assets around at multiple institutions." "The most reliable way to protect your important documents these days is to convert as many of them as possible to electronic form and save them in the cloud." "If you've worked hard in life it only makes sense to take some reasonable measures to protect what you've achieved." Episode references: Sentry Safes: https://www.sentrysafe.com Dropbox: https://www.dropbox.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Religious leaders and academic experts have faced a New South Wales parliamentary inquiry into a proposed law to combat right wing extremism. This, as the state government introduced the crime amendment bill following a neo-nazi protest outside state Parliament in November last year. The Law and Safety committee have been investigating the risks posed by certain groups, and are looking into the best ways to counter it. - दक्षिणपन्थी अतिवाद नियन्त्रण गर्न प्रस्तावित कानूनबारे न्यु साउथ वेल्सको संसदीय छानबिनमा विभिन्न धर्मगुरु र शैक्षिक विज्ञहरू यस हप्ता सहभागी भएका छन्। गत नोभेम्बरमा राज्यको संसद भवन अगाडी भएको एक नाजी समर्थक र्‍याली पछि सरकारले अपराध सम्बन्धि उक्त विधेयकमा संशोधनको प्रस्ताव गरेको थियो। कानून संशोधनका साथसाथै प्रभावकारी उपायहरूबारे छलफल गरिएको छ। एक रिपोर्ट।

This episode explores tadalafil (Cialis) as a potential longevity drug, though no randomized human trials prove it extends lifespan. Cialis works by blocking PDE5, enhancing nitric oxide signaling, and improving blood flow through vasodilation. Originally approved for pulmonary hypertension, it's also used for erectile dysfunction and BPH. Its 36-hour half-life makes it superior to Viagra for continuous longevity effects.   The host frames vascular aging and endothelial dysfunction as key drivers of age-related diseases (heart disease, stroke, dementia, kidney disease). Observational data shows Cialis users have 44% lower mortality, fewer cardiovascular events, reduced dementia risk, and lower mortality in diabetics. Additional benefits include improved cardiac function, reduced infarct size, arrhythmia suppression, and regression of left ventricular hypertrophy. A 2024 meta-analysis found it lowers hemoglobin A1C, possibly via improved microvascular perfusion, insulin sensitivity, and mitochondrial function.   Cialis crosses the blood-brain barrier and may improve neurovascular coupling and hippocampal plasticity, potentially benefiting those with or at risk of dementia. Safety is generally good with long-term daily use (2.5–5 mg), though cautions include avoiding use with nitrates, low blood pressure, or certain retinal disorders. Common side effects are headache, nasal congestion, and acid reflux. The host recommends consulting a doctor and references potential synergy with telmisartan.   Tadalafil (Cialis) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a604008.html](https://medlineplus.gov/druginfo/meds/a604008.html) Sildenafil (Viagra) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a699015.html](https://medlineplus.gov/druginfo/meds/a699015.html)   Key mechanisms mentioned Nitric Oxide (NO) — NCBI Bookshelf: [https://www.ncbi.nlm.nih.gov/books/NBK554485/](https://www.ncbi.nlm.nih.gov/books/NBK554485/) Cyclic GMP (cGMP) — NCBI Bookshelf: [https://www.ncbi.nlm.nih.gov/books/NBK542234/](https://www.ncbi.nlm.nih.gov/books/NBK542234/)   Conditions mentioned in the episode Benign Prostatic Hyperplasia (BPH) — MedlinePlus: [https://medlineplus.gov/benignprostatichyperplasia.html](https://medlineplus.gov/benignprostatichyperplasia.html) Pulmonary Arterial Hypertension (PAH) — MedlinePlus: [https://medlineplus.gov/pulmonaryhypertension.html](https://medlineplus.gov/pulmonaryhypertension.html)   Blood pressure drug mentioned Telmisartan — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a601249.html](https://medlineplus.gov/druginfo/meds/a601249.html)   Other longevity / comparison drugs mentioned Metformin — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a696005.html](https://medlineplus.gov/druginfo/meds/a696005.html) Sirolimus (Rapamycin) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a602026.html](https://medlineplus.gov/druginfo/meds/a602026.html)   Side-effect helper mentioned Ibuprofen (Advil) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a682159.html](https://medlineplus.gov/druginfo/meds/a682159.html)   Dementia meds mentioned Donepezil (Aricept) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a697032.html](https://medlineplus.gov/druginfo/meds/a697032.html) Amantadine — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a682064.html](https://medlineplus.gov/druginfo/meds/a682064.html)   Lab markers mentioned Hemoglobin A1C (HbA1c) test — MedlinePlus lab test: [https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/](https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/) Insulin in blood test — MedlinePlus lab test: [https://medlineplus.gov/lab-tests/insulin-in-blood/](https://medlineplus.gov/lab-tests/insulin-in-blood/)   People referenced (where the claims were mentioned) Huberman Lab (Dr. Andrew Huberman) — site: [https://www.hubermanlab.com/](https://www.hubermanlab.com/) Clip about low-dose tadalafil (2.5–5mg) — X post: [https://x.com/tbpn/status/2022350426394534334](https://x.com/tbpn/status/2022350426394534334) Bryan Johnson (Blueprint) — site: [https://blueprint.bryanjohnson.com/](https://blueprint.bryanjohnson.com/) Dr. David Sinclair (Harvard profile) — site: [https://sinclair.hms.harvard.edu/people/david-sinclair](https://sinclair.hms.harvard.edu/people/david-sinclair)   Show Notes   00:00 Welcome to the Hart2Heart Podcast. 01:56 What Cialis Is: PDE5 Inhibition, cGMP & Nitric Oxide Explained 03:43 Approved Uses & Origin Story: Pulmonary Hypertension, ED, and BPH 05:33 Why Cialis Over Viagra: 36-Hour Half-Life & 24/7 Vascular Benefits 06:52 Vascular Aging 101: Endothelium, Perfusion, and Why It Drives Disease 11:14 What the Human Data Shows: Observational Evidence for Mortality, CVD & Dementia 13:04 Mechanisms Deep Dive: Heart Protection, Heart Failure, and Anti-Atherosclerosis 15:02 Cialis for Diabetics: Lowering A1C and Improving Insulin Sensitivity 16:21 Brain Effects: Blood–Brain Barrier, Neurovascular Coupling & Dementia Potential 18:21 Safety, Who Should Avoid It, and Daily Longevity Dosing (2.5–5 mg) + Wrap-Up   The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to cutting through the noise and uncovering the most effective strategies for optimizing health, longevity, and peak performance. This podcast dives deep into evidence-based approaches to hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise protocols, leveraging sunlight, and de-prescribing pharmaceuticals — using medications only when absolutely necessary. Beyond health science, we explore the intersection of public health and politics, exposing how policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being. Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary  (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as  Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen). If you're ready to take control of your health and performance, this podcast is for you.We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being.   Connect with Dr. Mike Hart Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart

Couples rarely fall apart overnight. They drift—moving from walking together to walking parallel. Distance is formed in small moments of turning away.In this episode, we explore how to break cycles of self-protection, renew our minds, and build emotional safety by choosing connection over control and presence over performance.The question isn't what the trail brings. It's how we walk it—together.

A scrapped Hunt for Ben Solo project from Steven Soderbergh exposes a deeper issue at Lucasfilm under The Walt Disney Company. From The Last Jedi fallout to canon rigidity after the Rise of Skywalker, this breakdown explores why modern Star Wars seems to reject auteur filmmakers in favour of safe, brand-managed storytelling, and what that means for the future of the galaxy far, far away.

Back in the 1800s, people had an outsized fear of being buried alive. Enter... THE SAFETY COFFIN!See omnystudio.com/listener for privacy information.

In part two of this conversation, Domino continues his story of living with Type 3c diabetes after surviving necrotizing pancreatitis. Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** Use code JUICEBOX to save 40% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

In this episode, I sit down to talk about what it really means to build a business that aligns with who you are now—not who you were when you first started. We dive into the identity shifts that happen as you grow, the courage it takes to evolve publicly, and how to navigate the tension between staying consistent and honoring your expansion. I share my thoughts on visibility, messaging, and the internal work required to lead at your next level. We also talk about the practical side of growth—refining your voice, simplifying your offers, and making strategic decisions that support both impact and income. This conversation is an honest look at what it takes to scale without abandoning yourself in the process. If you've been feeling the pull to pivot, expand, or show up in a bigger way, this episode will meet you right where you are—and challenge you to rise into what's next. Liked this episode? Make sure to subscribe to our podcast and leave a review with your takeaways, this helps us create the exact content you want!  KEY POINTS:  00:49 Renovation Update + Post-Retreat Come Down 02:13 What Unscripted Was Designed to Do  04:03 Why It'd Been 2 Years Since Hosting a Retreat 08:11 The God Prompt That Birthed Unscripted 13:10 How This Retreat Was Different 16:12 Fellowship, Safety, and Embodied Transformation 21:13 Stop Holding Back From Proximity 26:16 The 3 Biggest Transformations 28:07 Final Reflections, Gratitude & What's Next   QUOTABLES: “ There is such a difference between having knowledge, versus knowledge that is embodied and applied and rooted in to you as you walk out that door.” - Julie Solomon  “ It's not enough to be real. It's important to be real in the right environment. Because the right environment is going to be able to see you, meet you, and hold you at that caliber and at that level.”  - Julie Solomon   RESOURCES:

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3462: Darrow Kirkpatrick explores the hidden risks that come with building wealth in the digital age and offers smart, low-cost strategies to protect your financial life. From identity theft to hacking, he shows how simple actions, like freezing your credit and strengthening your passwords, can provide lasting peace of mind. Read along with the original article(s) here: https://www.caniretireyet.com/protecting-your-assets-in-a-digital-world/ Quotes to ponder: "Along with increasing financial assets come inevitable concerns about protecting what you have." "Every piece of paper that you discard is at risk, so every modern home probably needs a serviceable paper shredder." "Today's hacking tools are so sophisticated that it can be child's play to break into an account that is protected by any but the strongest passwords." Episode references: Roboform: https://www.roboform.com/ Equifax Credit Freeze: https://www.equifax.com/personal/credit-report-services/credit-freeze/ TransUnion Credit Freeze: https://www.transunion.com/credit-freeze Learn more about your ad choices. Visit megaphone.fm/adchoices

Updates on the DCA midair collision, JetBlue software glitch, Air India B787 fuel control switch, injuries on United B777 flight, and Toronto CRJ-900 rollover. Also, the AA CEO’s message to employees, DOT mandate to purge DEI, Portland International Jetport passenger volume, Elliott Management and Southwest, and flight attendant carry-on bags. Plus, our first report from the Singapore Airshow. Guest Air Accident Updates We look at some air accident and incident updates in the press: NTSB Chair Slams FAA for Ignoring Repeated Warnings, Says Midair Collision Was Preventable In this C-Span video, NTSB Chair Jennifer Homendy slams the FAA, saying that it let its guard down and ignored repeated warnings that ultimately led to the deadly midair collision near Washington Reagan National Airport on January 29, 2025, that killed 67 people. “We should be angry, because for years no one listened. This was preventable. This was 100 percent preventable,” Homendy says. Passengers on JetBlue Plane That Plummeted When Flight Computer “Glitched Out” Sue Airbus for Negligence The JetBlue A320 experienced a sudden “uncommanded loss of altitude,” initially attributed to a software glitch that Airbus believed could result from intense solar radiation. This led to an emergency worldwide recall in November 2025, with an estimated 6,000 A320-series aircraft affected. Three passengers on that flight are now suing Airbus for allowing an “unreasonably dangerous” glitch in the system to go unchecked. Those passengers question the solar flare explanation and claim that JetBlue was aware of a recurring issue with the Elevator and Aileron Computer (ELAC) system. No defect found in switch of jet grounded by Air India – regulator Pilots on an Air India B787-8 noticed that during engine start, the fuel control switch did not “remain positively latched in the run position when light vertical pressure was applied”. This happened twice. The third time, the switch operated normally. The Directorate General of Civil Aviation (DGCA) said that when the switches were operated according to Boeing’s recommended procedure, they were found to be “satisfactory”, staying at run instead of moving to cut-off. The DGCA reported that, when incorrectly handled, the switch would “move easily from run to cut-off”. See also, Pilot alert prompts Air India checks on all Boeing 787 fuel control switchesby Rachel Chitra. Three United Airlines Flight Attendants Seriously Injured After Air Traffic Control Failed To Alert Pilots Of Turbulence The NTSB has released its final report on the February 10, 2024, incident where a United Airlines 777-200 experienced a sudden drop, seriously injuring three flight attendants and throwing several passengers and an unsecured baby into the ceiling. The NTSB concluded that a contributing factor was air traffic controllers’ failure to alert the pilots of turbulence in the area. TSB Canada Releases Update on 2025 Toronto CRJ-900 Crash Investigation Photo Credit: TSB Canada. The accident occurred at Toronto/Lester B. Pearson International Airport (CYYZ) on February 17, 2025, when the CRJ-900 regional jet attempted to land and struck the runway hard, causing the right wing and tail section to separate from the fuselage. The plane flipped upside down and slid to a stop. The wreckage was transported to a hangar while the right wing, landing gear, wing box structure, and related parts were taken to the Transportation Safety Board of Canada (TSB) Engineering Laboratory in Ottawa for testing. The metallurgical analysis of the wing and landing-gear fractures is now being examined. Recordings from the flight data recorder, cockpit voice recorder, quick access recorder (QAR), and the enhanced ground proximity warning system have been examined. Data from prior flights on the same aircraft were also compared to the accident flight for context. Evidence was collected from NAV CANADA's Toronto surface movement guidance system and the airport's closed-circuit television footage. A full meteorological review, including wind data and soundings, has also been finalized to understand weather conditions at the time. Simulator sessions have been run. The full preliminary report is available here. Aviation News Under Pressure American Airlines CEO Robert Isom Tells Staff That Everything Will Be Alright In New Video Message In a new video message to staffers, American Airlines chief executive Robert Isom says, “As we look forward to 2026, it's with a lot of excitement and confidence. I know we're going to do better financially and operationally. We have a plan to be solidly profitable this year, which will mean good things for our customers, our shareholders, and all of you.” Isom articulated strategies concerning the customer experience, hub facility investments, maximizing the power of the AA network and fleet, new routes, new frontline team members, new aircraft, AAdvantage program changes, and doing a better job selling the AA product. Trump's U.S. Transportation Secretary Sean P. Duffy Doubles Down on Purging DEI From Our Skies, Calls on Airlines to Affirm Pilot Hiring is Merit-Based The FAA is issuing a new mandatory “Operations Specification” (OpSpec) requiring all commercial airlines to commit to merit-based hiring for pilots formally. The mandate (New Mandatory OpSpec A134, Merit-Based Pilot Hiring, for Certificate Holders Conducting Operations Under 14 CFR Part 121 [PDF]) is effective February 13, 2026. U.S. Transportation Secretary Sean P. Duffy said, “When families board their aircraft, they should fly with confidence knowing the pilot behind the controls is the best of the best. The American people don't care what their pilot looks like or their gender—they just care that they are most qualified man or woman for the job. Safety drives everything we do, and this commonsense measure will increase transparency between passengers and airlines.”  ALPA Statement on Pilot Training and Qualification Standards Capt. Jason Ambrosi, president of the Air Line Pilots Association, Int’l (ALPA), issued a statement that included: “All ALPA pilots are trained and evaluated to the same uncompromising standard regardless of race, gender, or background. A pilot’s identity has no bearing on their ability to safely operate an aircraft. What matters is training, experience, and qualification — and on that front, there are no shortcuts and no compromises. “At ALPA, our work to advance aviation safety never stops, and as always, ALPA airline pilots remain ready to safely transport passengers and cargo to their destinations. Safety is, and always will be, our number one priority.” Portland International Jetport logs busiest year in its history The Portland International Jetport had a record year in 2025, with more than 2.59 million passengers traveling through the airport. The previous record was 2.44 million in 2024. The Jetport says it became the first airport in New England to surpass its pre-pandemic passenger levels in 2023. Southwest Airlines Turns a Corner as Activist Investor Elliott Walks Away Elliott Management, an activist investor, began to acquire shares of Southwest stock in mid-2024. It bought enough shares to gain board representation and dictate the Airline's strategic and financial changes. As a result, we saw paid assigned seating, baggage fees, expiring travel credits, and adjustments to its Rapid Rewards program. Southwest also looked at asset sales and balance sheet strategies to fund share buybacks. But in late 2025, Elliott began reducing its stake, and by early February 2026, its ownership dropped to about 9 percent. Two Elliott representatives have resigned from the board at Southwest. Southwest Airlines Now Faces a Flight Attendant Backlash As Hand Luggage Woes Grow Southwest moved a dedicated overhead bin for crew members to the back of the plane, and flight attendants are not happy. Passengers sitting at the front of the plane who have paid more or have elite status find that bin space is an issue. Singapore Airshow 2026 Brian Coleman interviewed several people at the Singapore Airshow. In this episode, he talks with Dan McQuestin, the Bell Country Manager in Australia. Mentioned “How LiveATC Went Live” by Rob Mark in the February 2026 issue of AIN Online. Hosts this Episode Max Flight, our Main(e) Man Micah, Rob Mark, and Erin Applebaum.

The anointing is the supernatural ability to fulfill your God-given assignment. In the Old Testament, the anointing would come on a prophet or leader for an assignment, but might not remain. But now, since the book of Acts, the Holy Spirit has been poured out on all flesh, and we have received the Holy Spirit inside of us when we are born again. The anointing is a gift from God. A precious gift, we must learn to walk in and steward.  

Hotels train teams to spot human trafficking and other suspicious activity. Training alone doesn't solve the handoff problem. #NoVacancyNews I talk with Georgine Muntz (CEO) and Patty Jefferson (Chief Revenue Officer) at Visual Matrix about building reporting into the workflow so staff can act fast without leaving their job to go hunt down a manager.

In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. Louise Hecker, Associate Professor of Medicine at Baylor College of Medicine. Together, they dive into Louise's recent research exploring how psilocybin, the active compound in psychedelic mushrooms, may influence aging biology at the cellular and organismal level.Louise shares the story behind her curiosity about psilocybin, sparked by conversations with a friend and fueled by a lack of scientific answers. She explains how her team overcame regulatory hurdles to study the effects of psilocybin on human cells and aging mice. Their findings showed that psilocybin extended cellular lifespan and reduced hallmarks of aging, such as oxidative stress and DNA damage. In mice, regular dosing improved survival, reversed visible signs of aging, and affected organs beyond the brain.The conversation also covers the challenges of translating these findings into humans, the need for more research on dosing and safety, and the importance of funding in moving this field forward. Louise encourages listeners to stay curious, think beyond established paths, and keep an open mind as new questions and discoveries emerge in the science of aging.Guest-at-a-Glance

Join the email list to get a FREE private finger training clinic with Dr. Tyler Nelson (normally $10) www.thestruggleclimbingshow.com/strong   Support the Show on Patreon Get access to all Pro Clinics, bonus episodes, and more. https://www.patreon.com/thestruggleclimbingshow   Coach Nate Drolet is back for another thoughtful conversation, including: Reflecting on his recent Hueco Tanks trip Climbing while injured  Collecting rejections like Stephen King Are gym boulders too tall? The problem with "easy" classics Advice to his younger self Falling 101 Is Coca-Cola Coffee aid? - BIG THANKS TO THE AMAZING SPONSORS OF THE STRUGGLE WHO LOVE ROCK CLIMBING AS MUCH AS YOU DO: SCARPA: The best climbing shoes, trail runners, and hikers in the game! Score yourself a free SCARPA x STRUGGLE hat when you use code STRUGGLE at checkout at SCARPA.com. SCARPA, No Place Too Far. Kilter: Award winning, adjustable, light-up board. It's what I'm training on at home, and if you're psyched to join me then use code STRUGGLE at checkout when you build your board, and you'll score up to $1000 off plus a free gift pack let's goooo!   And check out ALL the show's awesome sponsors and exclusive deals at thestruggleclimbingshow.com/deals - Here are some AI generated show notes (hopefully the robots got it right) 00:00 Weekend Warrior Life: Busy Schedules & Climbing Ambitions 03:07 Coach Nate Returns: Fresh Off Waco Tanks (and a 16-hour Drive) 05:16 Why Waco Matters: History, Style, and Coming Back After 7 Years 08:02 The Mystery Hand Injury: Rehab, PT Visits, and Still Sending 10:29 Low Dryer Send Story: Deconditioned, Tactical, and ‘Sport Climb' a Boulder 14:05 Mindset Lesson: ‘Collecting Rejections' Between Try Day and Send Day 20:06 Bouldering Trip Strategy: Limited ‘Great Goes,' Rest, and Managing Stoke 25:58 Sponsor Break: Scarpa Veloce L + Kilter Board Training Setup 29:06 Ryan's Vegas Injury & The Big Question: Am I Too Old for Outdoor Bouldering? 33:05 Gyms Are Too Tall: Risk, Training Value, and Smarter Bouldering as We Age 37:04 Indoor vs Outdoor Bouldering: Skills, Safety, and Choosing Lowballs 43:02 Injuries Happen: Low Back Pain, Randomness, and Playing Devil's Advocate 43:59 Rope Climber's Dilemma: Are Outdoor Bouldering Falls Worth It at 46? 45:19 Movement vs Highballs: “British vs French” Boulders & Why Classics Get Tall 47:58 Finding Low-Risk Outdoor Classics: Traverses, Short Gems, and Star Ratings 50:46 Bulldog/Puppy Dog Strategy: Pads, Topouts, and Managing the Mental Crux 54:04 Topout Skills Bootcamp: Mantles, Slabs, and Safe Practice in Chattanooga 56:20 How to Fall Better: Rolling, Tumbling Drills, and Building Confidence تدريجيًا 01:07:55 Keeping Sport Fitness During a Boulder Phase: ARC, 4x4s, and Seasonal Planning 01:16:56 Wrap-Up & Plugs: Coaching, “Affordable Atrocities,” and Supporting the Channel   - Shoutout to Aiden Schlatter for supporting at the Hero level on Patreon. A hero indeed! - Follow along on Instagram and YouTube: @thestruggleclimbingshow  - This show is produced and hosted by Ryan Devlin, and edited by Glen Walker. The Struggle is carbon-neutral in partnership with The Honnold Foundation and is a proud member of the Plug Tone Audio Collective, a diverse group of the best, most impactful podcasts in the outdoor industry.     And now here are some buzzwords to help the almighty algorithm get this show in front of people who love to climb: rock climbing, rock climber, climbing, climber, bouldering, sport climbing, gym climbing, how to rock climb, donuts are amazing. Okay, whew, that's done. But hey, if you're a human that's actually reading this, and if you love this show (and love to climb) would you think about sharing this episode with a climber friend of yours? And shout it out on your socials? I'll send you a sticker for doing it. Just shoot me a message on IG – thanks so much!